SCOPUS 정보 검색 플랫폼

Clinical Virology: Third Edition

Volumn , Issue , 2022, Pages 673-707

Hepatitis B virus

(3) Thompson, Alexander J V a Bell, Sally J a Locarnini, Stephen A b

a ST VINCENT S HOSPITAL (Australia)

b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY (Australia)

Author keywords

Antiviral therapy; Hepatitis b virus (HBV); Serologic assays; Viral proteins; Viral replication

Indexed keywords

EID: 84987690841 PISSN: None EISSN: None Source Type: Book
DOI: 10.1128/9781555815981.ch31 Document Type: Chapter

Times cited : (2)

References (196)

1
- 0021992966
- The longterm serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma
- Alward, W. L., B. J. McMahon, D. B. Hall, W. L. Heyward, D. P. Francis, T. R. Bender. 1985. The longterm serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J. Infect. Dis. 151:604-609.
- (1985) J. Infect. Dis. , vol.151 , pp. 604-609
- Alward, W.L.¹ McMahon, B.J.² Hall, D.B.³ Heyward, W.L.⁴ Francis, D.P.⁵ Bender, T.R.⁶

2
- 0041853784
- Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase
- Angus, P., R. Vaughan, S. Xiong, H. Yang, W. Delaney, C. Gibbs, C. Brosgart, D. Colledge, R. Edwards, A. Ayres, A. Bartholomeusz, S. Locarnini. 2003. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 125:292-297.
- (2003) Gastroenterology , vol.125 , pp. 292-297
- Angus, P.¹ Vaughan, R.² Xiong, S.³ Yang, H.⁴ Delaney, W.⁵ Gibbs, C.⁶ Brosgart, C.⁷ Colledge, D.⁸ Edwards, R.⁹ Ayres, A.¹⁰ Bartholomeusz, A.¹¹ Locarnini, S.¹²

3
- 0026706346
- Hepadnaviral assembly is initiated by polymerase binding to the encap-sidation signal in the viral RNA genome
- Bartenschlager, R., H. Schaller. 1992. Hepadnaviral assembly is initiated by polymerase binding to the encap-sidation signal in the viral RNA genome. EMBO J. 11: 3413-3420.
- (1992) EMBO J. , vol.11 , pp. 3413-3420
- Bartenschlager, R.¹ Schaller, H.²

4
- 1642580790
- Hepatitis B virus genotypes: comparison of genotyping methods
- Bartholomeusz, A., S. Schaefer. 2004. Hepatitis B virus genotypes: comparison of genotyping methods. Rev. Med. Virol. 14:3-16.
- (2004) Rev. Med. Virol. , vol.14 , pp. 3-16
- Bartholomeusz, A.¹ Schaefer, S.²

5
- 2342433984
- Comparisons of the HBV and HIV polymerase, antiviral resistance mutations
- Bartholomeusz, A., B. G. Tehan, D. K. Chalmers. 2004. Comparisons of the HBV and HIV polymerase, antiviral resistance mutations. Antivir. Ther. 9:149-160.
- (2004) Antivir. Ther. , vol.9 , pp. 149-160
- Bartholomeusz, A.¹ Tehan, B.G.² Chalmers, D.K.³

6
- 0020365308
- Geographic distribution of HBsAg carriers in China
- Beasley, R. P., C. C. Lin, C. S. Chien, C. J. Chen, L. Y. Hwang. 1982. Geographic distribution of HBsAg carriers in China. Hepatology 2:553-556.
- (1982) Hepatology , vol.2 , pp. 553-556
- Beasley, R.P.¹ Lin, C.C.² Chien, C.S.³ Chen, C.J.⁴ Hwang, L.Y.⁵

7
- 33846514081
- Hepatitis B virus replication
- Beck, J., M. Nassal. 2007. Hepatitis B virus replication. World J Gastroenterol. 13:48-64.
- (2007) World J Gastroenterol. , vol.13 , pp. 48-64
- Beck, J.¹ Nassal, M.²

8
- 19944427569
- Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients
- Bell, S. J., A. Lau, A. Thompson, K. J. Watson, B. Demediuk, G. Shaw, R. Y. Chen, A. Ayres, L. Yuen, A. Bartholomeusz, S. A. Locarnini, P. V. Desmond. 2005. Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients. J. Clin. Virol. 32:122-127.
- (2005) J. Clin. Virol. , vol.32 , pp. 122-127
- Bell, S.J.¹ Lau, A.² Thompson, A.³ Watson, K.J.⁴ Demediuk, B.⁵ Shaw, G.⁶ Chen, R.Y.⁷ Ayres, A.⁸ Yuen, L.⁹ Bartholomeusz, A.¹⁰ Locarnini, S.A.¹¹ Desmond, P.V.¹²

9
- 0037383868
- Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection
- Besisik, F., C. Karaca, F. Akyuz, S. Horosanli, D. Onel, S. Badur, M. S. Sever, A. Danalioglu, K. Demir, S. Kay-makoglu, Y. Cakaloglu, A. Okten. 2003. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J. Hepatol. 38:506510.
- (2003) J. Hepatol. , vol.38 , pp. 506510
- Besisik, F.¹ Karaca, C.² Akyuz, F.³ Horosanli, S.⁴ Onel, D.⁵ Badur, S.⁶ Sever, M.S.⁷ Danalioglu, A.⁸ Demir, K.⁹ Kay-Makoglu, S.¹⁰ Cakaloglu, Y.¹¹ Okten, A.¹²

10
- 0037674664
- Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection
- Biswas, R., E. Tabor, C. C. Hsia, D. J. Wright, M. E. Laycock, E. W. Fiebig, L. Peddada, R. Smith, G. B. Schreiber, J. S. Epstein, G. J. Nemo, M. P. Busch. 2003. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 43:788-798.
- (2003) Transfusion , vol.43 , pp. 788-798
- Biswas, R.¹ Tabor, E.² Hsia, C.C.³ Wright, D.J.⁴ Laycock, M.E.⁵ Fiebig, E.W.⁶ Peddada, L.⁷ Smith, R.⁸ Schreiber, G.B.⁹ Epstein, J.S.¹⁰ Nemo, G.J.¹¹ Busch, M.P.¹²

11
- 0028095561
- Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell
- Bock, C. T., P. Schranz, C. H. Schroder, H. Zentgraf. 1994. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 8:215-229.
- (1994) Virus Genes , vol.8 , pp. 215-229
- Bock, C.T.¹ Schranz, P.² Schroder, C.H.³ Zentgraf, H.⁴

12
- 0024467438
- The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men
- Bodsworth, N., B. Donovan, B. N. Nightingale. 1989. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J. Infect. Dis. 160:577-582.
- (1989) J. Infect. Dis. , vol.160 , pp. 577-582
- Bodsworth, N.¹ Donovan, B.² Nightingale, B.N.³

13
- 0041854928
- International Medical Press, London, United Kingdom
- Bowden, S. 2002. Laboratory Diagnosis of Hepatitis B Infection. International Medical Press, London, United Kingdom.
- (2002) Laboratory Diagnosis of Hepatitis B Infection
- Bowden, S.¹

14
- 33646366401
- Serological and molecular diagnosis
- Bowden, S. 2006. Serological and molecular diagnosis. Semin. Liver Dis. 26:97-103.
- (2006) Semin. Liver Dis. , vol.26 , pp. 97-103
- Bowden, S.¹

15
- 0024448926
- Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors
- Brook, M. G., P. Karayiannis, H. C. Thomas. 1989. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors. Hepatology 10:761-763.
- (1989) Hepatology , vol.10 , pp. 761-763
- Brook, M.G.¹ Karayiannis, P.² Thomas, H.C.³

16
- 0036168816
- Outcome of anti-HBe positive chronic hepatitis B in alphainterferon treated and untreated patients: a long term cohort study
- Brunetto, M. R., F. Oliveri, B. Coco, G. Leandro, P. Colombatto, J. M. Gorin, F. Bonino. 2002. Outcome of anti-HBe positive chronic hepatitis B in alphainterferon treated and untreated patients: a long term cohort study. J. Hepatol. 36:263-270.
- (2002) J. Hepatol. , vol.36 , pp. 263-270
- Brunetto, M.R.¹ Oliveri, F.² Coco, B.³ Leandro, G.⁴ Colombatto, P.⁵ Gorin, J.M.⁶ Bonino, F.⁷

17
- 0029931208
- Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity
- Bruss, V., J. Hagelstein, E. Gerhardt, P. R. Galle. 1996. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology 218:396399.
- (1996) Virology , vol.218 , pp. 396399
- Bruss, V.¹ Hagelstein, J.² Gerhardt, E.³ Galle, P.R.⁴

18
- 34548311958
- Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis
- Buster, E. H., B. E. Hansen, M. Buti, J. Delwaide, C. Niederau, P. P. Michielsen, R. Flisiak, P. E. Zondervan, S. W. Schalm, H. L. Janssen. 2007. Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis. Hepatology 46: 388-394.
- (2007) Hepatology , vol.46 , pp. 388-394
- Buster, E.H.¹ Hansen, B.E.² Buti, M.³ Delwaide, J.⁴ Niederau, C.⁵ Michielsen, P.P.⁶ Flisiak, R.⁷ Zondervan, P.E.⁸ Schalm, S.W.⁹ Janssen, H.L.¹⁰

19
- 0030625754
- The clinical significance of surface antigen variants of hepatitis B virus
- Carman, W. F. 1997. The clinical significance of surface antigen variants of hepatitis B virus. J. Viral. Hepat. 4(Suppl. 1) :11-20.
- (1997) J. Viral. Hepat. , vol.4 , pp. 11-20
- Carman, W.F.¹

20
- 16044373245
- Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis
- Carman, W. F., C. Trautwein, F. J. van Deursen, K. Colman, E. Dornan, G. McIntyre, J. Waters, V. Kliem, R. Muller, H. C. Thomas, M. P. Manns. 1996. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 24:489-493.
- (1996) Hepatology , vol.24 , pp. 489-493
- Carman, W.F.¹ Trautwein, C.² Van Deursen, F.J.³ Colman, K.⁴ Dornan, E.⁵ McIntyre, G.⁶ Waters, J.⁷ Kliem, V.⁸ Muller, R.⁹ Thomas, H.C.¹⁰ Manns, M.P.¹¹

21
- 0025075422
- Vaccine-induced escape mutant of hepatitis B virus
- Carman, W. F., A. R. Zanetti, P. Karayiannis, J. Waters, G. Manzillo, E. Tanzi, A. J. Zuckerman, H. C. Thomas. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
- (1990) Lancet , vol.336 , pp. 325-329
- Carman, W.F.¹ Zanetti, A.R.² Karayiannis, P.³ Waters, J.⁴ Manzillo, G.⁵ Tanzi, E.⁶ Zuckerman, A.J.⁷ Thomas, H.C.⁸

22
- 0035663014
- The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis
- Chan, H. L., J. L. Tang, W. Tam, J. J. Sung. 2001. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis. Aliment. Pharmacol. Ther. 15: 1899-1905.
- (2001) Aliment. Pharmacol. Ther. , vol.15 , pp. 1899-1905
- Chan, H.L.¹ Tang, J.L.² Tam, W.³ Sung, J.J.⁴

23
- 0036792742
- Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong
- Chan, H. L., S. W. Tsang, M. L. Wong, C. H. Tse, N. W. Leung, F. K. Chan, J. J. Sung. 2002. Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong. Am. J. Gastroenterol. 97:2629-2633.
- (2002) Am. J. Gastroenterol. , vol.97 , pp. 2629-2633
- Chan, H.L.¹ Tsang, S.W.² Wong, M.L.³ Tse, C.H.⁴ Leung, N.W.⁵ Chan, F.K.⁶ Sung, J.J.⁷

24
- 0030965103
- Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
- Chang, M.-H., C.-J. Chen, M.-S. Lai, H.-M. Hsu, T.-C. Wu, M.-S. Kong, D.-C. Liang, W.-Y. Shau, D.-S. Chen for the Taiwan Childhood Hepatoma Study Group. 1997. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med. 336:1855-1859.
- (1997) N. Engl. J. Med. , vol.336 , pp. 1855-1859
- Chang, M.-H.¹ Chen, C.-J.² Lai, M.-S.³ Hsu, H.-M.⁴ Wu, T.-C.⁵ Kong, M.-S.⁶ Liang, D.-C.⁷ Shau, W.-Y.⁸ Chen, D.-S.⁹

25
- 33644818518
- A comparison of ente-cavir and lamivudine for HBeAg-positive chronic hepatitis B
- Chang, T. T., R. G. Gish, R. de Man, A. Gadano, J. Sollano, Y. C. Chao, A. S. Lok, K. H. Han, Z. Goodman, J. Zhu, A. Cross, D. DeHertogh, R. Wilber, R. Colonno, D. Apelian. 2006. A comparison of ente-cavir and lamivudine for HBeAg-positive chronic hepatitis B.N. Engl. J. Med. 354:1001-1010.
- (2006) N. Engl. J. Med. , vol.354 , pp. 1001-1010
- Chang, T.T.¹ Gish, R.G.² De Man, R.³ Gadano, A.⁴ Sollano, J.⁵ Chao, Y.C.⁶ Lok, A.S.⁷ Han, K.H.⁸ Goodman, Z.⁹ Zhu, J.¹⁰ Cross, A.¹¹ DeHertogh, D.¹² Wilber, R.¹³ Colonno, R.¹⁴ Apelian, D.¹⁵

26
- 29944436855
- Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
- Chen, C. J., H. I. Yang, J. Su, C. L. Jen, S. L. You, S. N. Lu, G. T. Huang, U. H. Iloeje. 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295:65-73.
- (2006) JAMA , vol.295 , pp. 65-73
- Chen, C.J.¹ Yang, H.I.² Su, J.³ Jen, C.L.⁴ You, S.L.⁵ Lu, S.N.⁶ Huang, G.T.⁷ Iloeje, U.H.⁸

27
- 33746675024
- Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study
- Chen, G., W. Lin, F. Shen, U. H. iloeje, W. T. London, A. A. Evans. 2006. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am. J. Gastroenterol. 101: 1797-1803.
- (2006) Am. J. Gastroenterol. , vol.101 , pp. 1797-1803
- Chen, G.¹ Lin, W.² Shen, F.³ Iloeje, U.H.⁴ London, W.T.⁵ Evans, A.A.⁶

28
- 1442355468
- Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination
- Chen, H. L., C. J. Chang, M. S. Kong, F. C. Huang, H. C. Lee, C. C. Lin, C. C. Liu, I. H. Lee, T. C. Wu, S. F. Wu, Y. H. Ni, H. Y. Hsu, D. S. Chen, M. H. Chang. 2004. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 39:58-63.
- (2004) Hepatology , vol.39 , pp. 58-63
- Chen, H.L.¹ Chang, C.J.² Kong, M.S.³ Huang, F.C.⁴ Lee, H.C.⁵ Lin, C.C.⁶ Liu, C.C.⁷ Lee, I.H.⁸ Wu, T.C.⁹ Wu, S.F.¹⁰ Ni, Y.H.¹¹ Hsu, H.Y.¹² Chen, D.S.¹³ Chang, M.H.¹⁴

29
- 0026786639
- The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host
- Chen, H. S., M. C. Kew, W. E. Hornbuckle, B. C. Tennant, P. J. Cote, J. L. Gerin, R. H. Purcell, R. H. Miller. 1992. The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host. J. Virol. 66:5682-5684.
- (1992) J. Virol. , vol.66 , pp. 5682-5684
- Chen, H.S.¹ Kew, M.C.² Hornbuckle, W.E.³ Tennant, B.C.⁴ Cote, P.J.⁵ Gerin, J.L.⁶ Purcell, R.H.⁷ Miller, R.H.⁸

30
- 0037221770
- Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro
- Chen, R. Y., R. Edwards, T. Shaw, D. Colledge, W. E. Delaney IV, H. Isom, S. Bowden, P. Desmond, S. A. Locarnini. 2003. Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro. Hepatology 37:27-35.
- (2003) Hepatology , vol.37 , pp. 27-35
- Chen, R.Y.¹ Edwards, R.² Shaw, T.³ Colledge, D.⁴ Delaney I.V, W.E.⁵ Isom, H.⁶ Bowden, S.⁷ Desmond, P.⁸ Locarnini, S.A.⁹

31
- 0032869876
- Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B
- Chien, R.-N., Y.-F. Liaw, M. Atkins for the Asian Hepatitis Lamivudine Trial Group. 1999. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Hepatology 30:770-774.
- (1999) Hepatology , vol.30 , pp. 770-774
- Chien, R.-N.¹ Liaw, Y.-F.² Atkins, M.³

32
- 0028916425
- Hepatitis B virus immunopathogenesis
- Chisari, F. V., C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
- (1995) Annu. Rev. Immunol. , vol.13 , pp. 29-60
- Chisari, F.V.¹ Ferrari, C.²

33
- 0036079898
- Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C
- Chu, C. J., M. Hussain, A. S. Lok. 2002. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 122:1756-1762.
- (2002) Gastroenterology , vol.122 , pp. 1756-1762
- Chu, C.J.¹ Hussain, M.² Lok, A.S.³

34
- 0041859593
- Prevalence of HBV precore/core promoter variants in the United States
- Chu, C. J., E. B. Keeffe, S. H. Han, R. P. Perrillo, A. D. Min, C. Soldevila-Pico, W. Carey, R. S. Brown, Jr., V. A. Luketic, N. Terrault, A. S. Lok. 2003. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 38:619-628.
- (2003) Hepatology , vol.38 , pp. 619-628
- Chu, C.J.¹ Keeffe, E.B.² Han, S.H.³ Perrillo, R.P.⁴ Min, A.D.⁵ Soldevila-Pico, C.⁶ Carey, W.⁷ Brown, R.S.⁸ Luketic, V.A.⁹ Terrault, N.¹⁰ Lok, A.S.¹¹

35
- 33845675367
- Entecavir resistance is rare in nucleoside naive patients with hepatitis B
- Colonno, R. J., R. Rose, C. J. Baldick, S. Levine, K. Pokornowski, C. F. Yu, A. Walsh, J. Fang, M. Hsu, C. Mazzucco, B. Eggers, S. Zhang, M. Plym, K. Kles-czewski, D. J. Tenney. 2006. Entecavir resistance is rare in nucleoside naive patients with hepatitis B. Hepatology 44:1656-1665.
- (2006) Hepatology , vol.44 , pp. 1656-1665
- Colonno, R.J.¹ Rose, R.² Baldick, C.J.³ Levine, S.⁴ Pokornowski, K.⁵ Yu, C.F.⁶ Walsh, A.⁷ Fang, J.⁸ Hsu, M.⁹ Mazzucco, C.¹⁰ Eggers, B.¹¹ Zhang, S.¹² Plym, M.¹³ Kles-czewski, K.¹⁴ Tenney, D.J.¹⁵

36
- 0141526143
- The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon
- Cooksley, G. 2003. The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon. J. Hepatol. 39(Suppl. 1):S143-S145.
- (2003) J. Hepatol. , vol.39 , pp. S143-S145
- Cooksley, G.¹

37
- 0344737590
- Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay
- Deguchi, M., N. Yamashita, M. Kagita, S. Asari, Y. Iwa-tani, T. Tsuchida, K. Iinuma, I. K. Mushahwar. 2004. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J. Virol. Methods 115:217-222.
- (2004) J. Virol. Methods , vol.115 , pp. 217-222
- Deguchi, M.¹ Yamashita, N.² Kagita, M.³ Asari, S.⁴ Iwa-tani, Y.⁵ Tsuchida, T.⁶ Iinuma, K.⁷ Mushahwar, I.K.⁸

38
- 0034968926
- Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation
- Delaney, W. E., IV, S. Locarnini, T. Shaw. 2001. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation. Antivir. Chem. Chemother. 12:1-35.
- (2001) Antivir. Chem. Chemother. , vol.12 , pp. 1-35
- Delaney I.V, W.E.¹ Locarnini, S.² Shaw, T.³

39
- 0142092372
- The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro
- Delaney, W. E., IV, H. Yang, C. E. Westland, K. Das, E. Arnold, C. S. Gibbs, M. D. Miller, S. Xiong. 2003. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J. Virol. 77:11833-11841.
- (2003) J. Virol. , vol.77 , pp. 11833-11841
- Delaney I.V, W.E.¹ Yang, H.² Westland, C.E.³ Das, K.⁴ Arnold, E.⁵ Gibbs, C.S.⁶ Miller, M.D.⁷ Xiong, S.⁸

40
- 0037221907
- Histological outcome during long-term lamivudine therapy
- Dienstag, J. L., R. D. Goldin, E. J. Heathcote, H. W. Hann, M. Woessner, S. L. Stephenson, S. Gardner, D. F. Gray, E. R. Schiff. 2003. Histological outcome during long-term lamivudine therapy. Gastroenterology 124: 105-117.
- (2003) Gastroenterology , vol.124 , pp. 105-117
- Dienstag, J.L.¹ Goldin, R.D.² Heathcote, E.J.³ Hann, H.W.⁴ Woessner, M.⁵ Stephenson, S.L.⁶ Gardner, S.⁷ Gray, D.F.⁸ Schiff, E.R.⁹

41
- 4644323573
- A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus
- Durantel, D., S. Carrouee-Durantel, B. Werle-Lapostolle, M. N. Brunelle, C. Pichoud, C. Trepo, F. Zoulim. 2004. A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus. Hepatology 40:855-864.
- (2004) Hepatology , vol.40 , pp. 855-864
- Durantel, D.¹ Carrouee-Durantel, S.² Werle-Lapostolle, B.³ Brunelle, M.N.⁴ Pichoud, C.⁵ Trepo, C.⁶ Zoulim, F.⁷

42
- 33646354729
- Different profiles of response to adefovir dipivoxil and factors that may influence response in patients with chronic hepatitis B
- Durantel, S., B. Werle, D. Durantel, C. Pichoud, G. Currie, S. Xiong, C. Brosgart, C. Trepo, F. Zoulim. 2004. Different profiles of response to adefovir dipivoxil and factors that may influence response in patients with chronic hepatitis B. Hepatology 40:654A.
- (2004) Hepatology , vol.40 , pp. 654A
- Durantel, S.¹ Werle, B.² Durantel, D.³ Pichoud, C.⁴ Currie, G.⁵ Xiong, S.⁶ Brosgart, C.⁷ Trepo, C.⁸ Zoulim, F.⁹

43
- 1342264978
- Proceedings of the European Association for the Study of the Liver (EASL) International Consensus Conference on Hepatitis September 14-16, 2002. Geneva, Switzerland.
- Elsevier. 2003. Proceedings of the European Association for the Study of the Liver (EASL) International Consensus Conference on Hepatitis B. September 14-16, 2002. Geneva, Switzerland. J. Hepatol. 39(Suppl. 1):S1-S235.
- (2003) J. Hepatol. , vol.39 , pp. S1-S235

44
- 0024239739
- Long-term follow-up of anti-HBe-positive chronic active hepatitis B
- Fattovich, G., L. Brollo, A. Alberti, P. Pontisso, G. Giustina, G. Realdi. 1988. Long-term follow-up of anti-HBe-positive chronic active hepatitis B. Hepatology 8:1651-1654.
- (1988) Hepatology , vol.8 , pp. 1651-1654
- Fattovich, G.¹ Brollo, L.² Alberti, A.³ Pontisso, P.⁴ Giustina, G.⁵ Realdi, G.⁶

45
- 0025981670
- Natural history and prognostic factors for chronic hepatitis type B
- Fattovich, G., L. Brollo, G. Giustina, F. Noventa, P. Pontisso, A. Alberti, G. Realdi, A. Ruol. 1991. Natural history and prognostic factors for chronic hepatitis type B. Gut 32:294-298.
- (1991) Gut , vol.32 , pp. 294-298
- Fattovich, G.¹ Brollo, L.² Giustina, G.³ Noventa, F.⁴ Pontisso, P.⁵ Alberti, A.⁶ Realdi, G.⁷ Ruol, A.⁸

46
- 0028896179
- Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B
- Fattovich, G., G. Giustina, S. W. Schalm, S. Hadziyan-nis, J. Sanchez-Tapias, P. Almasio, E. Christensen, K. Krogsgaard, F. Degos, M. Carneiro de Moura, et al., for The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. 1995. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. Hepatology 21:77-82.
- (1995) Hepatology , vol.21 , pp. 77-82
- Fattovich, G.¹ Giustina, G.² Schalm, S.W.³ Hadziyan-nis, S.⁴ Sanchez-Tapias, J.⁵ Almasio, P.⁶ Christensen, E.⁷ Krogsgaard, K.⁸ Degos, F.⁹ Carneiro De Moura, M.¹⁰

47
- 0041822178
- New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B
- Feld, J., J. Y. Lee, S. Locarnini. 2003. New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38:545-553.
- (2003) Hepatology , vol.38 , pp. 545-553
- Feld, J.¹ Lee, J.Y.² Locarnini, S.³

48
- 33646358475
- Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment
- Feld, J. J., E. J. Heathcote. 2006. Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment. Semin. Liver Dis. 26:116-129.
- (2006) Semin. Liver Dis. , vol.26 , pp. 116-129
- Feld, J.J.¹ Heathcote, E.J.²

49
- 3042767356
- Mixed cryoglobulinemia: demographic, clinical, serologic features and survival in 231 patients
- Ferri, C., M. Sebastiani, D. Giuggioli, M. Cazzato, G. Longombardo, A. Antonelli, R. Puccini, C. Michelassi, A. L. Zignego. 2004. Mixed cryoglobulinemia: demographic, clinical, serologic features and survival in 231 patients. Semin. Arthritis Rheum. 33:355-374.
- (2004) Semin. Arthritis Rheum. , vol.33 , pp. 355-374
- Ferri, C.¹ Sebastiani, M.² Giuggioli, D.³ Cazzato, M.⁴ Longombardo, G.⁵ Antonelli, A.⁶ Puccini, R.⁷ Michelassi, C.⁸ Zignego, A.L.⁹

50
- 20444483260
- Long-term efficacy of hepatitis B vaccine, booster policy, impact of hepatitis B virus mutants
- Fitzsimons, D., G. Francois, A. Hall, B. McMahon, A. Meheus, A. Zanetti, B. Duval, W. Jilg, W. O. Bocher, S. N. Lu, U. Akarca, D. Lavanchy, S. Goldstein, J. Ban-atvala, P. V. Damme. 2005. Long-term efficacy of hepatitis B vaccine, booster policy, impact of hepatitis B virus mutants. Vaccine 23:4158-4166.
- (2005) Vaccine , vol.23 , pp. 4158-4166
- Fitzsimons, D.¹ Francois, G.² Hall, A.³ McMahon, B.⁴ Meheus, A.⁵ Zanetti, A.⁶ Duval, B.⁷ Jilg, W.⁸ Bocher, W.O.⁹ Lu, S.N.¹⁰ Akarca, U.¹¹ Lavanchy, D.¹² Goldstein, S.¹³ Banatvala, J.¹⁴ Damme, P.V.¹⁵

51
- 33644882231
- Treatment with Peginterferon a-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype
- Flink, H. J., M. van Zonneveld, B. E. Hansen, R. A. de Man, S. W. Schalm, H. L. A. Janssen for the HBV 99-01 Study Group. 2006. Treatment with Peginterferon a-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype. Am. J. Gastroenterol. 101:297-303.
- (2006) Am. J. Gastroenterol. , vol.101 , pp. 297-303
- Flink, H.J.¹ Van Zonneveld, M.² Hansen, B.E.³ De Man, R.A.⁴ Schalm, S.W.⁵ Janssen, H.L.A.⁶

52
- 33646361167
- Role of baseline and on-treatment quantitative HBeAg levels in predicting response to Peginterferon alfa-2a (40kD) (Pegasys) monotherapy in a large, multinational trial of patients with chronic hepatitis B
- Fried, M., Y.-F. Liaw, K. Luo. 2005. Role of baseline and on-treatment quantitative HBeAg levels in predicting response to Peginterferon alfa-2a (40kD) (Pegasys) monotherapy in a large, multinational trial of patients with chronic hepatitis B. Hepatology 42:268A.
- (2005) Hepatology , vol.42 , pp. 268A
- Fried, M.¹ Liaw, Y.-F.² Luo, K.³

53
- 27744510332
- Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation
- Fung, S. K., P. Andreone, S. H. Han, K. Rajender Reddy, A. Regev, E. B. Keeffe, M. Hussain, C. Cursaro, P. Richtmyer, J. A. Marrero, A. S. Lok. 2005. Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. J. Hepatol. 43: 937-943.
- (2005) J. Hepatol. , vol.43 , pp. 937-943
- Fung, S.K.¹ Andreone, P.² Han, S.H.³ Rajender Reddy, K.⁴ Regev, A.⁵ Keeffe, E.B.⁶ Hussain, M.⁷ Cursaro, C.⁸ Richtmyer, P.⁹ Marrero, J.A.¹⁰ Lok, A.S.¹¹

54
- 33947304026
- Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation
- Gane, E. J., P. W. Angus, S. Strasser, D. H. Crawford, J. Ring, G. P. Jeffrey, G. W. McCaughan. 2007. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology 132:931-937.
- (2007) Gastroenterology , vol.132 , pp. 931-937
- Gane, E.J.¹ Angus, P.W.² Strasser, S.³ Crawford, D.H.⁴ Ring, J.⁵ Jeffrey, G.P.⁶ McCaughan, G.W.⁷

55
- 0024316283
- Mutation rate of the hepadnavirus genome
- Girones, R., R. H. Miller. 1989. Mutation rate of the hepadnavirus genome. Virology 170:595-597.
- (1989) Virology , vol.170 , pp. 595-597
- Girones, R.¹ Miller, R.H.²

56
- 33645073742
- Entecavir results in substantial virologic and biochemical improvement through 96 weeks of treatment in HBeAg(+) chronic hepatitis B patients (Study ETV-022)
- Gish, R., T. T. Chang, R. de Man, A. Gadano, J. Sollano, K. H. Han, A. Lok, J. Zhu, L. Fernandes. 2005. Entecavir results in substantial virologic and biochemical improvement through 96 weeks of treatment in HBeAg(+) chronic hepatitis B patients (Study ETV-022). Hepatology 42:267A.
- (2005) Hepatology , vol.42 , pp. 267A
- Gish, R.¹ Chang, T.T.² De Man, R.³ Gadano, A.⁴ Sollano, J.⁵ Han, K.H.⁶ Lok, A.⁷ Zhu, J.⁸ Fernandes, L.⁹

57
- 0033617583
- Viral clearance without destruction of infected cells during acute HBV infection
- Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
- (1999) Science , vol.284 , pp. 825-829
- Guidotti, L.G.¹ Rochford, R.² Chung, J.³ Shapiro, M.⁴ Purcell, R.⁵ Chisari, F.V.⁶

58
- 0032610898
- Naturally occurring variants of hepatitis B virus
- Gunther, S., L. Fischer, I. Pult, M. Sterneck, H. Will. 1999. Naturally occurring variants of hepatitis B virus. Adv. Virus Res. 52:25-137.
- (1999) Adv. Virus Res. , vol.52 , pp. 25-137
- Gunther, S.¹ Fischer, L.² Pult, I.³ Sterneck, M.⁴ Will, H.⁵

59
- 0029893071
- Epidemiology of hepatitis B infection in the Western Pacific and South East Asia
- Gust, I. D. 1996. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 38(Suppl. 2):S18-S23.
- (1996) Gut , vol.38 , pp. S18-S23
- Gust, I.D.¹

60
- 33847617729
- Sustained biochemical and virological remission after discontinuation of 4 to 5 years of adefovir dipivoxil (ADV) treatment in HBeAg-negative chronic hepatitis B
- Hadziyannis, S., I. Sevastianos, I. Rapt, N. Tassop-oulos. 2006. Sustained biochemical and virological remission after discontinuation of 4 to 5 years of adefovir dipivoxil (ADV) treatment in HBeAg-negative chronic hepatitis B. Hepatology 44:231A.
- (2006) Hepatology , vol.44 , pp. 231
- Hadziyannis, S.¹ Sevastianos, I.² Rapt, I.³ Tassopoulos, N.⁴

61
- 33646369150
- Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment
- Hadziyannis, S. J., G. V. Papatheodoridis. 2006. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin. Liver Dis. 26:130-141.
- (2006) Semin. Liver Dis. , vol.26 , pp. 130-141
- Hadziyannis, S.J.¹ Papatheodoridis, G.V.²

62
- 21244455293
- Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
- Hadziyannis, S. J., N. C. Tassopoulos, E. J. Heathcote, T. T. Chang, G. Kitis, M. Rizzetto, P. Marcellin, S. G. Lim, Z. Goodman, J. Ma, S. Arterburn, S. Xiong, G. Currie, C. L. Brosgart. 2005. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.N. Engl. J. Med. 352:2673-2681.
- (2005) N. Engl. J. Med. , vol.352 , pp. 2673-2681
- Hadziyannis, S.J.¹ Tassopoulos, N.C.² Heathcote, E.J.³ Chang, T.T.⁴ Kitis, G.⁵ Rizzetto, M.⁶ Marcellin, P.⁷ Lim, S.G.⁸ Goodman, Z.⁹ Ma, J.¹⁰ Arterburn, S.¹¹ Xiong, S.¹² Currie, G.¹³ Brosgart, C.L.¹⁴

63
- 34247562010
- Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel
- Hammer, S. M., M. S. Saag, M. Schechter, J. S. Montaner, R. T. Schooley, D. M. Jacobsen, M. A. Thompson, C. C. Carpenter, M. A. Fischl, B. G. Gazzard, J. M. Gatell, M. S. Hirsch, D. A. Katzenstein, D. D. Rich-man, S. Vella, P. G. Yeni, P. A. Volberding. 2006. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. Top. HIV Med. 14:827-843.
- (2006) Top. HIV Med. , vol.14 , pp. 827-843
- Hammer, S.M.¹ Saag, M.S.² Schechter, M.³ Montaner, J.S.⁴ Schooley, R.T.⁵ Jacobsen, D.M.⁶ Thompson, M.A.⁷ Carpenter, C.C.⁸ Fischl, M.A.⁹ Gazzard, B.G.¹⁰ Gatell, J.M.¹¹ Hirsch, M.S.¹² Katzenstein, D.A.¹³ Richman, D.D.¹⁴ Vella, S.¹⁵ Yeni, P.G.¹⁶ Volberding, P.A.¹⁷

64
- 2942620400
- Extrahepatic manifestations of chronic hepatitis B
- Han, S. H. 2004. Extrahepatic manifestations of chronic hepatitis B. Clin. Liver Dis. 8:403-418.
- (2004) Clin. Liver Dis. , vol.8 , pp. 403-418
- Han, S.H.¹

65
- 0036614299
- Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
- Hsu, Y. S., R. N. Chien, C. T. Yeh, I. S. Sheen, H. Y. Chiou, C. M. Chu, Y. F. Liaw. 2002. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35:15221527.
- (2002) Hepatology , vol.35 , pp. 15221527
- Hsu, Y.S.¹ Chien, R.N.² Yeh, C.T.³ Sheen, I.S.⁴ Chiou, H.Y.⁵ Chu, C.M.⁶ Liaw, Y.F.⁷

66
- 0032816238
- Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex
- Hu, Z., Z. Zhang, E. Doo, O. Coux, A. L. Goldberg, T. J. Liang. 1999. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J. Virol. 73:7231-7240.
- (1999) J. Virol. , vol.73 , pp. 7231-7240
- Hu, Z.¹ Zhang, Z.² Doo, E.³ Coux, O.⁴ Goldberg, A.L.⁵ Liang, T.J.⁶

67
- 0034011395
- Clinical relevance of hepatitis B viral mutations
- Hunt, C. M., J. M. McGill, M. I. Allen, L. D. Con-dreay. 2000. Clinical relevance of hepatitis B viral mutations. Hepatology 31:1037-1044.
- (2000) Hepatology , vol.31 , pp. 1037-1044
- Hunt, C.M.¹ McGill, J.M.² Allen, M.I.³ Condreay, L.D.⁴

68
- 33644858331
- Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
- Iloeje, U. H., H. I. Yang, J. Su, C. L. Jen, S. L. You, C. J. Chen. 2006. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130:678-686.
- (2006) Gastroenterology , vol.130 , pp. 678-686
- Iloeje, U.H.¹ Yang, H.I.² Su, J.³ Jen, C.L.⁴ You, S.L.⁵ Chen, C.J.⁶

69
- 18744399291
- Toll-like receptor signaling inhibits hepatitis B virus replication in vivo
- Isogawa, M., M. D. Robek, Y. Furuichi, F. V. Chisari. 2005. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J. Virol. 79:7269-7272.
- (2005) J. Virol. , vol.79 , pp. 7269-7272
- Isogawa, M.¹ Robek, M.D.² Furuichi, Y.³ Chisari, F.V.⁴

70
- 32944458551
- Chronic hepatitis B: HBeAg seroconversion after pegylated interferon and nucleos(t)ide analogs
- Janssen, H. L., G. K. Lau. 2005. Chronic hepatitis B: HBeAg seroconversion after pegylated interferon and nucleos(t)ide analogs. Hepatology 42:1459.
- (2005) Hepatology , vol.42 , pp. 1459
- Janssen, H.L.¹ Lau, G.K.²

71
- 0034596944
- Natural killer T cell activation inhibits hepatitis B virus replication in vivo
- Kakimi, K., L. G. Guidotti, Y. Koezuka, F. V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192:921930.
- (2000) J. Exp. Med. , vol.192 , pp. 921-930
- Kakimi, K.¹ Guidotti, L.G.² Koezuka, Y.³ Chisari, F.V.⁴

72
- 0002800729
- Hepadnaviridae: structure and molecular virology, p 77-105.
- A.J. Zuckerman and H.C. Thomas (ed.), Churchill Livingstone, New York, NY
- Kann, M. 1998. Hepadnaviridae: structure and molecular virology, p. 77-105. In A.J. Zuckerman and H.C. Thomas (ed.), Viral Hepatitis, 2nd ed. Churchill Livingstone, New York, NY.
- (1998) Viral Hepatitis, 2nd ed.
- Kann, M.¹

73
- 0344197102
- Clinical relevance of hepatitis B virus genotypes Ba and Bj in Taiwan
- Kao, J. H., D. S. Chen. 2003. Clinical relevance of hepatitis B virus genotypes Ba and Bj in Taiwan. Gastroenterology 125:1916-1917.
- (2003) Gastroenterology , vol.125 , pp. 1916-1917
- Kao, J.H.¹ Chen, D.S.²

74
- 84984535720
- Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
- Kao, J. H., P. J. Chen, M. Y. Lai, D. S. Chen. 2000. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118: 554-559.
- (2000) Gastroenterology , vol.118 , pp. 554-559
- Kao, J.H.¹ Chen, P.J.² Lai, M.Y.³ Chen, D.S.⁴

75
- 84984578737
- Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers
- Kao, J. H., P. J. Chen, M. Y. Lai, D. S. Chen. 2004. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J. Med. Virol. 72:363-369.
- (2004) J. Med. Virol. , vol.72 , pp. 363-369
- Kao, J.H.¹ Chen, P.J.² Lai, M.Y.³ Chen, D.S.⁴

76
- 0036292006
- Molecular mechanism of viral hepatocar-cinogenesis
- Koike, K., T. Tsutsumi, H. Fujie, Y. Shintani, M. Kyoji. 2002. Molecular mechanism of viral hepatocar-cinogenesis. Oncology 62(Suppl. 1):29-37.
- (2002) Oncology , vol.62 , pp. 29-37
- Koike, K.¹ Tsutsumi, T.² Fujie, H.³ Shintani, Y.⁴ Kyoji, M.⁵

77
- 0031769390
- The long-term effect of treatment with interferon-a2a in chronic hepatitis B
- Krogsgaard, K., the Long-Term Follow-up Investigator Group, Executive Team on Anti-Viral Treatment. 1998. The long-term effect of treatment with interferon-a2a in chronic hepatitis B.J. Viral Hepat. 5:389-397.
- (1998) J. Viral Hepat. , vol.5 , pp. 389-397
- Krogsgaard, K.¹

78
- 33846447769
- A randomized controlled trial of lamivudine to treat acute hepatitis B
- Kumar, M., S. Satapathy, R. Monga, K. Das, S. Hissar, C. Pande, B. C. Sharma, S. K. Sarin. 2007. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 45:97-101.
- (2007) Hepatology , vol.45 , pp. 97-101
- Kumar, M.¹ Satapathy, S.² Monga, R.³ Das, K.⁴ Hissar, S.⁵ Pande, C.⁶ Sharma, B.C.⁷ Sarin, S.K.⁸

79
- 0037443950
- Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B
- Lai, C. L., J. Dienstag, E. Schiff, N. W. Leung, M. Atkins, C. Hunt, N. Brown, M. Woessner, R. Boehme, L. Condreay. 2003. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin. Infect. Dis. 36:687-696.
- (2003) Clin. Infect. Dis. , vol.36 , pp. 687-696
- Lai, C.L.¹ Dienstag, J.² Schiff, E.³ Leung, N.W.⁴ Atkins, M.⁵ Hunt, C.⁶ Brown, N.⁷ Woessner, M.⁸ Boehme, R.⁹ Condreay, L.¹⁰

80
- 23244453590
- A 1-year trial of tel-bivudine, lamivudine, the combination in patients with hepatitis B e antigen-positive chronic hepatitis B
- Lai, C. L., N. Leung, E. K. Teo, M. Tong, F. Wong, H. W. Hann, S. Han, T. Poynard, M. Myers, G. Chao, D. Lloyd, N. A. Brown. 2005. A 1-year trial of tel-bivudine, lamivudine, the combination in patients with hepatitis B e antigen-positive chronic hepatitis B. Gastroenterology 129:528-536.
- (2005) Gastroenterology , vol.129 , pp. 528-536
- Lai, C.L.¹ Leung, N.² Teo, E.K.³ Tong, M.⁴ Wong, F.⁵ Hann, H.W.⁶ Han, S.⁷ Poynard, T.⁸ Myers, M.⁹ Chao, G.¹⁰ Lloyd, D.¹¹ Brown, N.A.¹²

81
- 32444438958
- Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine
- Lampertico, P., M. Vigano, E. Manenti, M. Iavarone, G. Lunghi, M. Colombo. 2005. Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine. Hepatology 42: 1414-1419.
- (2005) Hepatology , vol.42 , pp. 1414-1419
- Lampertico, P.¹ Vigano, M.² Manenti, E.³ Iavarone, M.⁴ Lunghi, G.⁵ Colombo, M.⁶

82
- 33748939050
- Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients
- Laras, A., J. Koskinas, E. Dimou, A. Kostamena, S. J. Hadziyannis. 2006. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 44: 694-702.
- (2006) Hepatology , vol.44 , pp. 694-702
- Laras, A.¹ Koskinas, J.² Dimou, E.³ Kostamena, A.⁴ Hadziyannis, S.J.⁵

83
- 21244447705
- Peginterferon alfa-2a, lamivudine, the combination for HBeAg-positive chronic hepatitis B
- Lau, G. K., T. Piratvisuth, K. X. Luo, P. Marcellin, S. Thongsawat, G. Cooksley, E. Gane, M. W. Fried, W. C. Chow, S. W. Paik, W. Y. Chang, T. Berg, R. Flisiak, P. McCloud, N. Pluck. 2005. Peginterferon alfa-2a, lamivudine, the combination for HBeAg-positive chronic hepatitis B.N. Engl. J. Med. 352:2682-2695.
- (2005) N. Engl. J. Med. , vol.352 , pp. 2682-2695
- Lau, G.K.¹ Piratvisuth, T.² Luo, K.X.³ Marcellin, P.⁴ Thongsawat, S.⁵ Cooksley, G.⁶ Gane, E.⁷ Fried, M.W.⁸ Chow, W.C.⁹ Paik, S.W.¹⁰ Chang, W.Y.¹¹ Berg, T.¹² Flisiak, R.¹³ McCloud, P.¹⁴ Pluck, N.¹⁵

84
- 10744222282
- Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy
- Lau, G. K., H. H. Yiu, D. Y. Fong, H. C. Cheng, W. Y. Au, L. S. Lai, M. Cheung, H. Y. Zhang, A. Lie, R. Ngan, R. Liang. 2003. Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy. Gastroenterology 125:1742-1749.
- (2003) Gastroenterology , vol.125 , pp. 1742-1749
- Lau, G.K.¹ Yiu, H.H.² Fong, D.Y.³ Cheng, H.C.⁴ Au, W.Y.⁵ Lai, L.S.⁶ Cheung, M.⁷ Zhang, H.Y.⁸ Lie, A.⁹ Ngan, R.¹⁰ Liang, R.¹¹

85
- 1642410856
- Hepatitis B virus epidemiology, disease burden, treatment, current and emerging prevention and control measures
- Lavanchy, D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, current and emerging prevention and control measures. J. Viral. Hepat. 11:97-107.
- (2004) J. Viral. Hepat. , vol.11 , pp. 97-107
- Lavanchy, D.¹

86
- 33745570056
- Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy
- Lee, Y. S., D. J. Suh, Y. S. Lim, S. W. Jung, K. M. Kim, H. C. Lee, Y. H. Chung, W. Yoo, S. O. Kim. 2006. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. Hepatology 43:13851391.
- (2006) Hepatology , vol.43 , pp. 1385-1391
- Lee, Y.S.¹ Suh, D.J.² Lim, Y.S.³ Jung, S.W.⁴ Kim, K.M.⁵ Lee, H.C.⁶ Chung, Y.H.⁷ Yoo, W.⁸ Kim, S.O.⁹

87
- 32444450074
- The effect of pegylated interferon-alpha on the treatment of lami-vudine resistant chronic HBeAg positive hepatitis B virus infection
- Leemans, W. F., H. J. Flink, H. L. Janssen, H. G. Nies-ters, S. W. Schalm, R. A. de Man. 2006. The effect of pegylated interferon-alpha on the treatment of lami-vudine resistant chronic HBeAg positive hepatitis B virus infection. J. Hepatol. 44:507-511.
- (2006) J. Hepatol. , vol.44 , pp. 507-511
- Leemans, W.F.¹ Flink, H.J.² Janssen, H.L.³ Niesters, H.G.⁴ Schalm, S.W.⁵ De Man, R.A.⁶

88
- 20444363583
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
- Liaw, Y. F., N. Leung, R. Guan, G. K. Lau, I. Merican, G. McCaughan, E. Gane, J. H. Kao, M. Omata. 2005. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int. 25: 472-489.
- (2005) Liver Int. , vol.25 , pp. 472-489
- Liaw, Y.F.¹ Leung, N.² Guan, R.³ Lau, G.K.⁴ Merican, I.⁵ McCaughan, G.⁶ Gane, E.⁷ Kao, J.H.⁸ Omata, M.⁹

89
- 0025753470
- Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study
- Liaw, Y. F., I. S. Sheen, T. J. Chen, C. M. Chu, C. C. Pao. 1991. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 13:627-631.
- (1991) Hepatology , vol.13 , pp. 627-631
- Liaw, Y.F.¹ Sheen, I.S.² Chen, T.J.³ Chu, C.M.⁴ Pao, C.C.⁵

90
- 19544391413
- Lamivudine for patients with chronic hepatitis B and advanced liver disease
- Liaw, Y. F., J. J. Sung, W. C. Chow, G. Farrell, C. Z. Lee, H. Yuen, T. Tanwandee, Q. M. Tao, K. Shue, O. N. Keene, J. S. Dixon, D. F. Gray, J. Sabbat. 2004. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N. Engl. J. Med. 351:15211531.
- (2004) N. Engl. J. Med. , vol.351 , pp. 1521-1531
- Liaw, Y.F.¹ Sung, J.J.² Chow, W.C.³ Farrell, G.⁴ Lee, C.Z.⁵ Yuen, H.⁶ Tanwandee, T.⁷ Tao, Q.M.⁸ Shue, K.⁹ Keene, O.N.¹⁰ Dixon, J.S.¹¹ Gray, D.F.¹² Sabbat, J.¹³

91
- 28144449129
- The development of cirrhosis in patients with chronic type B hepatitis: a prospective study
- Liaw, Y. F., D. I. Tai, C. M. Chu, T. J. Chen. 1988. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 8:493496.
- (1988) Hepatology , vol.8 , pp. 493496
- Liaw, Y.F.¹ Tai, D.I.² Chu, C.M.³ Chen, T.J.⁴

92
- 34548513797
- Viral quasi-species evolution during hepatitis B e antigen seroconversion
- Lim, S. G., Y. Cheng, S. Guindon, B. L. Seet, L. Y. Lee, P. Hu, S. Wasser, F. J. Peter, T. Tan, M. Goode, A. G. Rodrigo. 2007. Viral quasi-species evolution during hepatitis B e antigen seroconversion. Gastroenterology 133:951-958.
- (2007) Gastroenterology , vol.133 , pp. 951-958
- Lim, S.G.¹ Cheng, Y.² Guindon, S.³ Seet, B.L.⁴ Lee, L.Y.⁵ Hu, P.⁶ Wasser, S.⁷ Peter, F.J.⁸ Tan, T.⁹ Goode, M.¹⁰ Rodrigo, A.G.¹¹

93
- 30344457555
- A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B
- Lim, S. G., T. M. Ng, N. Kung, Z. Krastev, M. Volfova, P. Husa, S. S. Lee, S. Chan, M. L. Shiffman, M. K. Washington, A. Rigney, J. Anderson, E. Mondou, A. Snow, J. Sorbel, R. Guan, F. Rousseau. 2006. A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B. Arch. Intern. Med. 166:49-56.
- (2006) Arch. Intern. Med. , vol.166 , pp. 49-56
- Lim, S.G.¹ Ng, T.M.² Kung, N.³ Krastev, Z.⁴ Volfova, M.⁵ Husa, P.⁶ Lee, S.S.⁷ Chan, S.⁸ Shiffman, M.L.⁹ Washington, M.K.¹⁰ Rigney, A.¹¹ Anderson, J.¹² Mondou, E.¹³ Snow, A.¹⁴ Sorbel, J.¹⁵ Guan, R.¹⁶ Rousseau, F.¹⁷

94
- 84984549645
- Basal corepromoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B
- Lin, C. L., L. Y. Liao, C. S. Wang, P. J. Chen, M. Y. Lai, D. S. Chen, J. H. Kao. 2005. Basal corepromoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. Liver Int. 25:564-570.
- (2005) Liver Int. , vol.25 , pp. 564-570
- Lin, C.L.¹ Liao, L.Y.² Wang, C.S.³ Chen, P.J.⁴ Lai, M.Y.⁵ Chen, D.S.⁶ Kao, J.H.⁷

95
- 0033027690
- Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection
- Lin, S. M., I. S. Sheen, R. N. Chien, C. M. Chu, Y. F. Liaw. 1999. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 29:971-975.
- (1999) Hepatology , vol.29 , pp. 971-975
- Lin, S.M.¹ Sheen, I.S.² Chien, R.N.³ Chu, C.M.⁴ Liaw, Y.F.⁵

96
- 33845636202
- Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F
- Livingston, S. E., J. P. Simonetti, B. J. McMahon, L. R. Bulkow, K. J. Hurlburt, C. E. Homan, M. M. Snowball, H. H. Cagle, J. L. Williams, V. P. Chulanov. 2007. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F.J. Infect. Dis. 195:5-11.
- (2007) J. Infect. Dis. , vol.195 , pp. 5-11
- Livingston, S.E.¹ Simonetti, J.P.² McMahon, B.J.³ Bulkow, L.R.⁴ Hurlburt, K.J.⁵ Homan, C.E.⁶ Snowball, M.M.⁷ Cagle, H.H.⁸ Williams, J.L.⁹ Chulanov, V.P.¹⁰

97
- 0022361229
- Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers
- Lo, K. J., Y. T. Tsai, S. D. Lee, T. C. Wu, J. Y. Wang, G. H. Chen, C. L. Yeh, B. N. Chiang, S. H. Yeh, A. Goudeau, P. Coursaget, M. Tong. 1985. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J. Infect. Dis. 152:817-822.
- (1985) J. Infect. Dis. , vol.152 , pp. 817-822
- Lo, K.J.¹ Tsai, Y.T.² Lee, S.D.³ Wu, T.C.⁴ Wang, J.Y.⁵ Chen, G.H.⁶ Yeh, C.L.⁷ Chiang, B.N.⁸ Yeh, S.H.⁹ Goudeau, A.¹⁰ Coursaget, P.¹¹ Tong, M.¹²

98
- 24344478565
- Molecular virology and the development of resistant mutants: implications for therapy
- Locarnini, S. 2005. Molecular virology and the development of resistant mutants: implications for therapy. Semin. Liver Dis. 25(Suppl. 1):9-19.
- (2005) Semin. Liver Dis. , vol.25 , pp. 9-19
- Locarnini, S.¹

99
- 7244262077
- Management of antiviral resistance in patients with chronic hepatitis B
- Locarnini, S., A. Hatzakis, J. Heathcote, E. B. Keeffe, T. J. Liang, D. Mutimer, J. M. Pawlotsky, F. Zou-lim. 2004. Management of antiviral resistance in patients with chronic hepatitis B. Antivir. Ther. 9:679693.
- (2004) Antivir. Ther. , vol.9 , pp. 679693
- Locarnini, S.¹ Hatzakis, A.² Heathcote, J.³ Keeffe, E.B.⁴ Liang, T.J.⁵ Mutimer, D.⁶ Pawlotsky, J.M.⁷ Zou-lim, F.⁸

100
- 0037198749
- Chronic hepatitis B
- Lok, A. S. 2002. Chronic hepatitis B.N. Engl. J. Med. 346:1682-1683.
- (2002) N. Engl. J. Med. , vol.346 , pp. 1682-1683
- Lok, A.S.¹

101
- 0028222146
- Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pregenome encapsidation signal
- Lok, A. S., U. Akarca, S. Greene. 1994. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pregenome encapsidation signal. Proc. Natl. Acad. Sci. USA 91:4077-4081.
- (1994) Proc. Natl. Acad. Sci. USA , vol.91 , pp. 4077-4081
- Lok, A.S.¹ Akarca, U.² Greene, S.³

102
- 0023243960
- Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection
- Lok, A. S., C. L. Lai, P. C. Wu, E. K. Leung, T. S. Lam. 1987. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 92:1839-1843.
- (1987) Gastroenterology , vol.92 , pp. 1839-1843
- Lok, A.S.¹ Lai, C.L.² Wu, P.C.³ Leung, E.K.⁴ Lam, T.S.⁵

103
- 33847701354
- Chronic hepatitis B
- Lok, A. S., B. J. McMahon. 2007. Chronic hepatitis B. Hepatology 45:507-539.
- (2007) Hepatology , vol.45 , pp. 507-539
- Lok, A.S.¹ McMahon, B.J.²

104
- 0030691203
- Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States
- Mahoney, F. J., K. Stewart, H. Hu, P. Coleman, M. J. Alter. 1997. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch. Intern. Med. 157:26012605.
- (1997) Arch. Intern. Med. , vol.157 , pp. 26012605
- Mahoney, F.J.¹ Stewart, K.² Hu, H.³ Coleman, P.⁴ Alter, M.J.⁵

105
- 0034678435
- The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection
- Maini, M. K., C. Boni, C. K. Lee, J. R. Larrubia, S. Reignat, G. S. Ogg, A. S. King, J. Herberg, R. Gilson, A. Alisa, R. Williams, D. Vergani, N. V. Naoumov, C. Ferrari, A. Bertoletti. 2000. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191:1269-1280.
- (2000) J. Exp. Med. , vol.191 , pp. 1269-1280
- Maini, M.K.¹ Boni, C.² Lee, C.K.³ Larrubia, J.R.⁴ Reignat, S.⁵ Ogg, G.S.⁶ King, A.S.⁷ Herberg, J.⁸ Gilson, R.⁹ Alisa, A.¹⁰ Williams, R.¹¹ Vergani, D.¹² Naoumov, N.V.¹³ Ferrari, C.¹⁴ Bertoletti, A.¹⁵

106
- 0034950006
- Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B
- Manesis, E. K., S. J. Hadziyannis. 2001. Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B. Gastroenterology 121:101-109.
- (2001) Gastroenterology , vol.121 , pp. 101-109
- Manesis, E.K.¹ Hadziyannis, S.J.²

107
- 4544239807
- Peginterferon alfa-2a alone, lamivudine alone, the two in combination in patients with HBeAg-negative chronic hepatitis B
- Marcellin, P., G. K. Lau, F. Bonino, P. Farci, S. Had-ziyannis, R. Jin, Z. M. Lu, T. Piratvisuth, G. German-idis, C. Yurdaydin, M. Diago, S. Gurel, M. Y. Lai, P. Button, N. Pluck. 2004. Peginterferon alfa-2a alone, lamivudine alone, the two in combination in patients with HBeAg-negative chronic hepatitis B.N. Engl. J. Med. 351:1206-1217.
- (2004) N. Engl. J. Med. , vol.351 , pp. 1206-1217
- Marcellin, P.¹ Lau, G.K.² Bonino, F.³ Farci, P.⁴ Had-Ziyannis, S.⁵ Jin, R.⁶ Lu, Z.M.⁷ Piratvisuth, T.⁸ German-idis, G.⁹ Yurdaydin, C.¹⁰ Diago, M.¹¹ Gurel, S.¹² Lai, M.Y.¹³ Button, P.¹⁴ Pluck, N.¹⁵

108
- 0027306019
- Serology of acute exacerbation in chronic hepatitis B virus infection
- Maruyama, T., S. Iino, K. Koike, K. Yasuda, D. R. Milich. 1993. Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology 105: 1141-1151.
- (1993) Gastroenterology , vol.105 , pp. 1141-1151
- Maruyama, T.¹ Iino, S.² Koike, K.³ Yasuda, K.⁴ Milich, D.R.⁵

109
- 0027302418
- The serology of chronic hepatitis B infection revisited
- Maruyama, T., A. McLachlan, S. Iino, K. Koike, K. Kurokawa, D. R. Milich. 1993. The serology of chronic hepatitis B infection revisited. J. Clin. Investig. 91:2586-2595.
- (1993) J. Clin. Investig. , vol.91 , pp. 2586-2595
- Maruyama, T.¹ McLachlan, A.² Iino, S.³ Koike, K.⁴ Kurokawa, K.⁵ Milich, D.R.⁶

110
- 0344959603
- Strategies to prevent and control hepatitis B and C virus infections: a global perspective
- Mast, E. E., M. J. Alter, H. S. Margolis. 1999. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 17:1730-1733.
- (1999) Vaccine , vol.17 , pp. 1730-1733
- Mast, E.E.¹ Alter, M.J.² Margolis, H.S.³

111
- 0025239328
- Hepatitis B: global importance and need for control
- discussion, S21-S23
- Maynard, J. E. 1990. Hepatitis B: global importance and need for control. Vaccine 8(Suppl. 1):S18-S20; discussion, S21-S23.
- (1990) Vaccine , vol.8 , pp. S18-S20
- Maynard, J.E.¹

112
- 0038023197
- Inhibition of hepatitis B virus in mice by RNA interference
- McCaffrey, A. P., H. Nakai, K. Pandey, Z. Huang, F. H. Salazar, H. Xu, S. F. Wieland, P. L. Marion, M. A. Kay. 2003. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21:639-644.
- (2003) Nat. Biotechnol. , vol.21 , pp. 639-644
- McCaffrey, A.P.¹ Nakai, H.² Pandey, K.³ Huang, Z.⁴ Salazar, F.H.⁵ Xu, H.⁶ Wieland, S.F.⁷ Marion, P.L.⁸ Kay, M.A.⁹

113
- 0033951066
- Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines
- McClary, H., R. Koch, F. V. Chisari, L. G. Gui-dotti. 2000. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol. 74:2255-2264.
- (2000) J. Virol. , vol.74 , pp. 2255-2264
- McClary, H.¹ Koch, R.² Chisari, F.V.³ Guidotti, L.G.⁴

114
- 20044369702
- Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up
- McMahon, B. J., D. L. Bruden, K. M. Petersen, L. R. Bulkow, A. J. Parkinson, O. Nainan, M. Khristova, C. Zanis, H. Peters, H. S. Margolis. 2005. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann. Intern. Med. 142:333-341.
- (2005) Ann. Intern. Med. , vol.142 , pp. 333-341
- McMahon, B.J.¹ Bruden, D.L.² Petersen, K.M.³ Bulkow, L.R.⁴ Parkinson, A.J.⁵ Nainan, O.⁶ Khristova, M.⁷ Zanis, C.⁸ Peters, H.⁹ Margolis, H.S.¹⁰

115
- 34250722018
- The HBV drug entecavir-effects on HIV-1 replication and resistance
- McMahon, M. A., B. L. Jilek, T. P. Brennan, L. Shen, Y. Zhou, M. Wind-Rotolo, S. Xing, S. Bhat, B. Hale, R. Hegarty, C. R. Chong, J. O. Liu, R. F. Siliciano, C. L. Thio. 2007. The HBV drug entecavir-effects on HIV-1 replication and resistance. N. Engl. J. Med. 356:2614-2621.
- (2007) N. Engl. J. Med. , vol.356 , pp. 2614-2621
- McMahon, M.A.¹ Jilek, B.L.² Brennan, T.P.³ Shen, L.⁴ Zhou, Y.⁵ Wind-Rotolo, M.⁶ Xing, S.⁷ Bhat, S.⁸ Hale, B.⁹ Hegarty, R.¹⁰ Chong, C.R.¹¹ Liu, J.O.¹² Siliciano, R.F.¹³ Thio, C.L.¹⁴

116
- 0142151773
- Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection
- Milich, D., T. J. Liang. 2003. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38:1075-1086.
- (2003) Hepatology , vol.38 , pp. 1075-1086
- Milich, D.¹ Liang, C.L.²

117
- 0025147370
- Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
- Milich, D. R., J. E. Jones, J. L. Hughes, J. Price, A. K. Raney, A. McLachlan. 1990. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc. Natl. Acad. Sci. USA 87:6599-6603.
- (1990) Proc Natl. Acad. Sci. USA , vol.87 , pp. 6599-6603
- Milich, D.R.¹ Jones, J.E.² Hughes, J.L.³ Price, J.⁴ Raney, A.K.⁵ McLachlan, A.⁶

118
- 0022611628
- Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg
- Milich, D. R., A. McLachlan, F. V. Chisari, S. B. Kent, G. B. Thorton. 1986. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg. J. Immunol. 137:315-322.
- (1986) J. Immunol. , vol.137 , pp. 315-322
- Milich, D.R.¹ McLachlan, A.² Chisari, F.V.³ Kent, S.B.⁴ Thorton, G.B.⁵

119
- 0021971098
- Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen
- Milich, D. R., G. B. Thornton, A. R. Neurath, S. B. Kent, M. L. Michel, P. Tiollais, F. V. Chisari. 1985. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228:1195-1199.
- (1985) Science , vol.228 , pp. 1195-1199
- Milich, D.R.¹ Thornton, G.B.² Neurath, A.R.³ Kent, S.B.⁴ Michel, M.L.⁵ Tiollais, P.⁶ Chisari, F.V.⁷

120
- 0029037074
- The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes
- Newbold, J. E., H. Xin, M. Tencza, G. Sherman, J. Dean, S. Bowden, S. Locarnini. 1995. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J. Virol. 69:3350-3357.
- (1995) J. Virol. , vol.69 , pp. 3350-3357
- Newbold, J.E.¹ Xin, H.² Tencza, M.³ Sherman, G.⁴ Dean, J.⁵ Bowden, S.⁶ Locarnini, S.⁷

121
- 34247209063
- Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies
- Ni, Y. H., L. M. Huang, M. H. Chang, C. J. Yen, C. Y. Lu, S. L. You, J. H. Kao, Y. C. Lin, H. L. Chen, H. Y. Hsu, D. S. Chen. 2007. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 132:1287-1293.
- (2007) Gastroenterology , vol.132 , pp. 1287-1293
- Ni, Y.H.¹ Huang, L.M.² Chang, M.H.³ Yen, C.J.⁴ Lu, C.Y.⁵ You, S.L.⁶ Kao, J.H.⁷ Lin, Y.C.⁸ Chen, H.L.⁹ Hsu, H.Y.¹⁰ Chen, D.S.¹¹

122
- 0029893146
- Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
- Niederau, C., T. Heintges, S. Lange, G. Goldmann, C. M. Niederau, L. Mohr, D. Haussinger. 1996. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.N. Engl. J. Med. 334:1422-1427.
- (1996) N. Engl. J. Med. , vol.334 , pp. 1422-1427
- Niederau, C.¹ Heintges, T.² Lange, S.³ Goldmann, G.⁴ Niederau, C.M.⁵ Mohr, L.⁶ Haussinger, D.⁷

123
- 29244442587
- Hepatitis B virus infection: current status
- Ocama, P., C. K. Opio, W. M. Lee. 2005. Hepatitis B virus infection: current status. Am. J. Med. 118:1413.
- (2005) Am. J. Med. , vol.118 , pp. 1413
- Ocama, P.¹ Opio, C.K.² Lee, W.M.³

124
- 0027992963
- Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen
- Okamoto, H., F. Tsuda, Y. Akahane, Y. Sugai, M. Yoshiba, K. Moriyama, T. Tanaka, Y. Miyakawa, M. Mayumi. 1994. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J. Virol. 68:8102-8110.
- (1994) J. Virol. , vol.68 , pp. 8102-8110
- Okamoto, H.¹ Tsuda, F.² Akahane, Y.³ Sugai, Y.⁴ Yoshiba, M.⁵ Moriyama, K.⁶ Tanaka, T.⁷ Miyakawa, Y.⁸ Mayumi, M.⁹

125
- 21344460718
- Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine
- Papatheodoridis, G. V., E. Dimou, K. Dimakopoulos, S. Manolakopoulos, I. Rapti, G. Kitis, D. Tzourmak-liotis, E. Manesis, S. J. Hadziyannis. 2005. Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine. Hepatology 42:121-129.
- (2005) Hepatology , vol.42 , pp. 121-129
- Papatheodoridis, G.V.¹ Dimou, E.² Dimakopoulos, K.³ Manolakopoulos, S.⁴ Rapti, I.⁵ Kitis, G.⁶ Tzourmak-liotis, D.⁷ Manesis, E.⁸ Hadziyannis, S.J.⁹

126
- 0035110693
- The long-term outcome of interferonalpha treated and untreated patients with HBeAg-negative chronic hepatitis B
- Papatheodoridis, G. V., E. Manesis, S. J. Hadzi-yannis. 2001. The long-term outcome of interferonalpha treated and untreated patients with HBeAg-negative chronic hepatitis B.J. Hepatol. 34:306-313.
- (2001) J. Hepatol. , vol.34 , pp. 306-313
- Papatheodoridis, G.V.¹ Manesis, E.² Hadzi-yannis, S.J.³

127
- 33846902868
- Long-term outcome of chronic hepatitis B based on histological grade and stage
- Park, B. K., Y. N. Park, S. H. Ahn, K. S. Lee, C. Y. Chon, Y. M. Moon, C. Park, K. H. Han. 2007. Long-term outcome of chronic hepatitis B based on histological grade and stage. J. Gastroenterol. Hepatol. 22: 383-388.
- (2007) J. Gastroenterol. Hepatol. , vol.22 , pp. 383-388
- Park, B.K.¹ Park, Y.N.² Ahn, S.H.³ Lee, K.S.⁴ Chon, C.Y.⁵ Moon, Y.M.⁶ Park, C.⁷ Han, K.H.⁸

128
- 14844325741
- Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B
- Park, N. H., J. W. Shin, J. H. Park, S. J. Bang, D. H. Kim, K. R. Joo. 2005. Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B.J. Viral. Hepat. 12:216-221.
- (2005) J. Viral. Hepat. , vol.12 , pp. 216-221
- Park, N.H.¹ Shin, J.W.² Park, J.H.³ Bang, S.J.⁴ Kim, D.H.⁵ Joo, K.R.⁶

129
- 0036094158
- Molecular diagnosis of viral hepatitis
- Pawlotsky, J. M. 2002. Molecular diagnosis of viral hepatitis. Gastroenterology 122:1554-1568.
- (2002) Gastroenterology , vol.122 , pp. 1554-1568
- Pawlotsky, J.M.¹

130
- 0029087266
- Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus
- Perrillo, R., C. Tamburro, F. Regenstein, L. Balart, H. Bodenheimer, M. Silva, E. Schiff, C. Bodicky, B. Miller, C. Denham, C. Brodeur, K. Roach, J. Albrecht. 1995. Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus. Gastroenterology 109:908-916.
- (1995) Gastroenterology , vol.109 , pp. 908-916
- Perrillo, R.¹ Tamburro, C.² Regenstein, F.³ Balart, L.⁴ Bodenheimer, H.⁵ Silva, M.⁶ Schiff, E.⁷ Bodicky, C.⁸ Miller, B.⁹ Denham, C.¹⁰ Brodeur, C.¹¹ Roach, K.¹² Albrecht, J.¹³

131
- 24344444416
- Current treatment of chronic hepatitis B: benefits and limitations
- Perrillo, R. P. 2005. Current treatment of chronic hepatitis B: benefits and limitations. Semin. Liver Dis. 25(Suppl. 1):20-28.
- (2005) Semin. Liver Dis. , vol.25 , pp. 20-28
- Perrillo, R.P.¹

132
- 0025347975
- A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B
- Perrillo, R. P., E. R. Schiff, G. L. Davis, H. C. Bod-enheimer, Jr., K. Lindsay, J. Payne, J. L. Dienstag, C. O'Brien, C. Tamburro, I. M. Jacobson, R. Sampliner, D. Feit, J. Lefkowitch, M. Kuhns, C. Meschievitz, B. Sanghvi, J. Albrecht, A. Gibes, The Hepatitis Interventional Therapy Group. 1990. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B.N. Engl. J. Med. 323:295-301.
- (1990) N. Engl. J. Med. , vol.323 , pp. 295-301
- Perrillo, R.P.¹ Schiff, E.R.² Davis, G.L.³ Bodenheimer, H.C.⁴ Lindsay, K.⁵ Payne, J.⁶ Dienstag, J.L.⁷ O'Brien, C.⁸ Tamburro, C.⁹ Jacobson, I.M.¹⁰ Sampliner, R.¹¹ Feit, D.¹² Lefkowitch, J.¹³ Kuhns, M.¹⁴ Meschievitz, C.¹⁵ Sanghvi, B.¹⁶ Albrecht, J.¹⁷ Gibes, A.¹⁸

133
- 0031811079
- Hepatitis B immunization in health care workers, Dealing with vaccine nonresponse.
- Poland, G. A. 1998. Hepatitis B immunization in health care workers. Dealing with vaccine nonresponse. Am. J. Prev. Med. 15:73-77.
- (1998) Am. J. Prev. Med. , vol.15 , pp. 73-77
- Poland, G.A.¹

134
- 16544365632
- Clinical practice: prevention of hepatitis B with the hepatitis B vaccine
- Poland, G. A., R. M. Jacobson. 2004. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N. Engl. J. Med. 351:2832-2838.
- (2004) N. Engl. J. Med. , vol.351 , pp. 2832-2838
- Poland, G.A.¹ Jacobson, R.M.²

135
- 0042692926
- Nuclear import of hepatitis B virus capsids and release of the viral genome
- Rabe, B., A. Vlachou, N. Pante, A. Helenius, M. Kann. 2003. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc. Natl. Acad. Sci. USA 100:9849-9854.
- (2003) Proc. Natl. Acad. Sci. USA , vol.100 , pp. 9849-9854
- Rabe, B.¹ Vlachou, A.² Pante, N.³ Helenius, A.⁴ Kann, M.⁵

136
- 34047189890
- Occult hepatitis B virus infection
- Raimondo, G., T. Pollicino, I. Cacciola, G. Squadrito. 2007. Occult hepatitis B virus infection. J. Hepatol. 46:160-170.
- (2007) J. Hepatol. , vol.46 , pp. 160-170
- Raimondo, G.¹ Pollicino, T.² Cacciola, I.³ Squadrito, G.⁴

137
- 33847709539
- Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B
- Rapti, I., E. Dimou, P. Mitsoula, S. J. Hadziyannis. 2007. Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B. Hepatology 45:307-313.
- (2007) Hepatology , vol.45 , pp. 307-313
- Rapti, I.¹ Dimou, E.² Mitsoula, P.³ Hadziyannis, S.J.⁴

138
- 0027998132
- Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study
- Realdi, G., G. Fattovich, S. Hadziyannis, S. W. Schalm, P. Almasio, J. Sanchez-Tapias, E. Christensen, G. Giustina, F. Noventa for The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). 1994. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J. Hepatol. 21:656-666.
- (1994) J. Hepatol. , vol.21 , pp. 656-666
- Realdi, G.¹ Fattovich, G.² Hadziyannis, S.³ Schalm, S.W.⁴ Almasio, P.⁵ Sanchez-Tapias, J.⁶ Christensen, E.⁷ Giustina, G.⁸ Noventa, F.⁹

139
- 0026514186
- Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator
- Rossner, M. T. 1992. Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator. J. Med. Virol. 36:101-117.
- (1992) J. Med. Virol. , vol.36 , pp. 101-117
- Rossner, M.T.¹

140
- 0035240915
- An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques
- Saldanha, J., W. Gerlich, N. Lelie, P. Dawson, K. Heermann, A. Heath. 2001. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang. 80:6371.
- (2001) Vox Sang. , vol.80 , pp. 63-71
- Saldanha, J.¹ Gerlich, W.² Lelie, N.³ Dawson, P.⁴ Heermann, K.⁵ Heath, A.⁶

141
- 33846531835
- Hepatitis B virus taxonomy and hepatitis B virus genotypes
- Schaefer, S. 2007. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J. Gastroenterol. 13:1421.
- (2007) World J. Gastroenterol. , vol.13 , pp. 1421
- Schaefer, S.¹

142
- 33947427581
- Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results
- Schiff, E., C.-L. Lai, S. Hadziyannis, P. Neuhaus, N. Terrault, M. Colombo, H. Tillmann, D. Samuel, S. Zeuzem, J.-P. Villeneuve, S. Arterburn, K. Borroto-Esoda, C. Brosgart, S. Chuck for the Adefovir Dipivoxil Study 435 International Investigators Group. 2007. Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results. Liver Transplant. 13:349-360.
- (2007) Liver Transplant. , vol.13 , pp. 349-360
- Schiff, E.¹ Lai, C.-L.² Hadziyannis, S.³ Neuhaus, P.⁴ Terrault, N.⁵ Colombo, M.⁶ Tillmann, H.⁷ Samuel, D.⁸ Zeuzem, S.⁹ Villeneuve, J.-P.¹⁰ Arterburn, S.¹¹ Borroto-Esoda, K.¹² Brosgart, C.¹³ Chuck, S.¹⁴

143
- 0001940783
- Biosynthesis and enzymatic functions of the hepadna-viral reverse transcriptase, p 171-180.
- A. McLachlan (ed.), CRC Press, Boca Raton, FL
- Schlicht, H., R. Bartenschlager, H. Schaller. 1991. Biosynthesis and enzymatic functions of the hepadna-viral reverse transcriptase, p. 171-180. In A. McLachlan (ed.), Molecular Biology of the Hepatitis B Viruses. CRC Press, Boca Raton, FL.
- (1991) Molecular Biology of the Hepatitis B Viruses.
- Schlicht, H.¹ Bartenschlager, R.² Schaller, H.³

144
- 0029942003
- The risk of transfusion-transmitted viral infections
- Schreiber, G. B., M. P. Busch, S. H. Kleinman, J. J. Korelitz for The Retrovirus Epidemiology Donor Study. 1996. The risk of transfusion-transmitted viral infections. N. Engl. J. Med. 334:1685-1690.
- (1996) N. Engl. J. Med. , vol.334 , pp. 1685-1690
- Schreiber, G.B.¹ Busch, M.P.² Kleinman, S.H.³ Korelitz, J.J.⁴

145
- 9944225067
- Entecavir for the treatment of chronic hepatitis B
- Shaw, T., S. Locarnini. 2004. Entecavir for the treatment of chronic hepatitis B. Expert Rev. Anti-Infect. Ther. 2:853-871.
- (2004) Expert Rev. Anti-Infect. Ther. , vol.2 , pp. 853-871
- Shaw, T.¹ Locarnini, S.²

146
- 0023236064
- The natural history of hepatitis B
- Sherlock, S. 1987. The natural history of hepatitis B. Postgrad. Med. J. 63(Suppl. 2):7-11.
- (1987) Postgrad. Med. J. , vol.63 , pp. 7-11
- Sherlock, S.¹

147
- 33744531146
- Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B
- Sherman, M., C. Yurdaydin, J. Sollano, M. Silva, Y. F. Liaw, J. Cianciara, A. Boron-Kaczmarska, P. Martin, Z. Goodman, R. Colonno, A. Cross, G. Denisky, B. Kreter, R. Hindes. 2006. Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B. Gastroenterology 130:2039-2049.
- (2006) Gastroenterology , vol.130 , pp. 2039-2049
- Sherman, M.¹ Yurdaydin, C.² Sollano, J.³ Silva, M.⁴ Liaw, Y.F.⁵ Cianciara, J.⁶ Boron-Kaczmarska, A.⁷ Martin, P.⁸ Goodman, Z.⁹ Colonno, R.¹⁰ Cross, A.¹¹ Denisky, G.¹² Kreter, B.¹³ Hindes, R.¹⁴

148
- 0024974106
- Liver transplantation (1)
- Starzl, T. E., A. J. Demetris, D. Van Thiel. 1989. Liver transplantation (1). N. Engl. J. Med. 321:10141022.
- (1989) N. Engl. J. Med. , vol.321 , pp. 1014-1022
- Starzl, T.E.¹ Demetris, A.J.² Van Thiel, D.³

149
- 0021241388
- Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen
- Stephan, W., A. M. Prince, B. Brotman. 1984. Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen. J. Virol. 51:420-424.
- (1984) J. Virol. , vol.51 , pp. 420-424
- Stephan, W.¹ Prince, A.M.² Brotman, B.³

150
- 0016693477
- Vertical transmission of hepatitis B antigen in Taiwan
- Stevens, C. E., R. P. Beasley, J. Tsui, W. C. Lee. 1975. Vertical transmission of hepatitis B antigen in Taiwan. N. Engl. J. Med. 292:771-774.
- (1975) N. Engl. J. Med. , vol.292 , pp. 771-774
- Stevens, C.E.¹ Beasley, R.P.² Tsui, J.³ Lee, W.C.⁴

151
- 84944365708
- Perinatal hepatitis B virus transmission in the United States
- Stevens, C. E., P. T. Toy, M. J. Tong, P. E. Taylor, G. N. Vyas, P. V. Nair, M. Gudavalli, S. Krugman. 1985. Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA 253:1740-1745.
- (1985) Prevention by passive-active immunization. JAMA , vol.253 , pp. 1740-1745
- Stevens, C.E.¹ Toy, P.T.² Tong, M.J.³ Taylor, P.E.⁴ Vyas, G.N.⁵ Nair, P.V.⁶ Gudavalli, M.⁷ Krugman, S.⁸

152
- 0033957572
- A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness
- Stuyver, L., S. De Gendt, C. Van Geyt, F. Zoulim, M. Fried, R. F. Schinazi, R. Rossau. 2000. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J. Gen. Virol. 81:67-74.
- (2000) J. Gen. Virol. , vol.81 , pp. 67-74
- Stuyver, L.¹ De Gendt, S.² Van Geyt, C.³ Zoulim, F.⁴ Fried, M.⁵ Schinazi, R.F.⁶ Rossau, R.⁷

153
- 17744375593
- Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region
- Stuyver, L. J., S. A. Locarnini, A. Lok, D. D. Rich-man, W. F. Carman, J. L. Dienstag, R. F. Schinazi. 2001. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 33:751-757.
- (2001) Hepatology , vol.33 , pp. 751-757
- Stuyver, L.J.¹ Locarnini, S.A.² Lok, A.³ Richman, D.D.⁴ Carman, W.F.⁵ Dienstag, J.L.⁶ Schinazi, R.F.⁷

154
- 33750633962
- Influence of hepatitis B virus genotypes on the intra-and extracellular expression of viral DNA and antigens
- Sugiyama, M., Y. Tanaka, T. Kato, E. Orito, K. Ito, S. K. Acharya, R. G. Gish, A. Kramvis, T. Shimada, N. Izumi, M. Kaito, Y. Miyakawa, M. Mizokami. 2006. Influence of hepatitis B virus genotypes on the intra-and extracellular expression of viral DNA and antigens. Hepatology 44:915-924.
- (2006) Hepatology , vol.44 , pp. 915-924
- Sugiyama, M.¹ Tanaka, Y.² Kato, T.³ Orito, E.⁴ Ito, K.⁵ Acharya, S.K.⁶ Gish, R.G.⁷ Kramvis, A.⁸ Shimada, T.⁹ Izumi, N.¹⁰ Kaito, M.¹¹ Miyakawa, Y.¹² Mizokami, M.¹³

155
- 0037219388
- Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease
- Sumi, H., O. Yokosuka, N. Seki, M. Arai, F. Imazeki, T. Kurihara, T. Kanda, K. Fukai, M. Kato, H. Saisho. 2003. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 37:19-26.
- (2003) Hepatology , vol.37 , pp. 19-26
- Sumi, H.¹ Yokosuka, O.² Seki, N.³ Arai, M.⁴ Imazeki, F.⁵ Kurihara, T.⁶ Kanda, T.⁷ Fukai, K.⁸ Kato, M.⁹ Saisho, H.¹⁰

156
- 4344627233
- Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine
- Tenney, D. J., S. M. Levine, R. E. Rose, A. W. Walsh, S. P. Weinheimer, L. Discotto, M. Plym, K. Pokor-nowski, C. F. Yu, P. Angus, A. Ayres, A. Bartholo-meusz, W. Sievert, G. Thompson, N. Warner, S. Locarnini, R. J. Colonno. 2004. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine. Antimicrob. Agents Chemother. 48:3498-3507.
- (2004) Antimicrob. Agents Chemother. , vol.48 , pp. 3498-3507
- Tenney, D.J.¹ Levine, S.M.² Rose, R.E.³ Walsh, A.W.⁴ Weinheimer, S.P.⁵ Discotto, L.⁶ Plym, M.⁷ Pokornowski, K.⁸ Yu, C.F.⁹ Angus, P.¹⁰ Ayres, A.¹¹ Bartholo-Meusz, A.¹² Sievert, W.¹³ Thompson, G.¹⁴ Warner, N.¹⁵ Locarnini, S.¹⁶ Colonno, R.J.¹⁷

157
- 0037016387
- Primary infection with a lamivudine-resistant hepatitis B virus
- Thibault, V., C. Aubron-Olivier, H. Agut, C. Katlama. 2002. Primary infection with a lamivudine-resistant hepatitis B virus. AIDS 16:131-133.
- (2002) AIDS , vol.16 , pp. 131-133
- Thibault, V.¹ Aubron-Olivier, C.² Agut, H.³ Katlama, C.⁴

158
- 0037213545
- CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection
- Thimme, R., S. Wieland, C. Steiger, J. Ghrayeb, K. A. Reimann, R. H. Purcell, F. V. Chisari. 2003. CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77:6876.
- (2003) J. Virol. , vol.77 , pp. 68-76
- Thimme, R.¹ Wieland, S.² Steiger, C.³ Ghrayeb, J.⁴ Reimann, K.A.⁵ Purcell, R.H.⁶ Chisari, F.V.⁷

159
- 34248353565
- Treatment of HIV/ HBV coinfection: clinical and virologic issues
- Thio, C. L., S. Locarnini. 2007. Treatment of HIV/ HBV coinfection: clinical and virologic issues. AIDS Rev. 9:40-53.
- (2007) AIDS Rev. , vol.9 , pp. 40-53
- Thio, C.L.¹ Locarnini, S.²

160
- 0037079352
- HIV-1, hepatitis B virus, risk of liver-related mortality in the Multicenter Cohort Study (MACS)
- Thio, C. L., E. C. Seaberg, R. Skolasky, Jr., J. Phair, B. Visscher, A. Munoz, D. L. Thomas. 2002. HIV-1, hepatitis B virus, risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360: 1921-1926.
- (2002) Lancet , vol.360 , pp. 1921-1926
- Thio, C.L.¹ Seaberg, E.C.² Skolasky, R.³ Phair, J.⁴ Visscher, B.⁵ Munoz, A.⁶ Thomas, D.L.⁷

161
- 34548382183
- Hepatocyte interleukin-1 receptor and toll-like receptor signalling: effects on HBV replication in vitro
- Thompson, A. J. V., D. S. Preiss, X. Chen, P. Revill, P. Desmond, K. Visvanathan, S. A. Locarnini. 2006. Hepatocyte interleukin-1 receptor and toll-like receptor signalling: effects on HBV replication in vitro. Hepatology 44:537A.
- (2006) Hepatology , vol.44 , pp. 537
- Thompson, A.J.V.¹ Preiss, D.S.² Chen, X.³ Revill, P.⁴ Desmond, P.⁵ Visvanathan, K.⁶ Locarnini, S.A.⁷

162
- 33645083207
- Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience
- Tillmann, H. L., J. Hadem, L. Leifeld, K. Zachou, A. Canbay, C. Eisenbach, I. Graziadei, J. Encke, H. Schmidt, W. Vogel, A. Schneider, U. Spengler, G. Ger-ken, G. N. Dalekos, H. Wedemeyer, M. P. Manns. 2006. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J. Viral Hepat. 13:256-263.
- (2006) J. Viral Hepat. , vol.13 , pp. 256-263
- Tillmann, H.L.¹ Hadem, J.² Leifeld, L.³ Zachou, K.⁴ Canbay, A.⁵ Eisenbach, C.⁶ Graziadei, I.⁷ Encke, J.⁸ Schmidt, H.⁹ Vogel, W.¹⁰ Schneider, A.¹¹ Spengler, U.¹² Gerken, G.¹³ Dalekos, G.N.¹⁴ Wedemeyer, H.¹⁵ Manns, M.P.¹⁶

163
- 0036059889
- Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy
- Torresi, J., L. Earnest-Silveira, G. Deliyannis, K. Edgt-ton, H. Zhuang, S. A. Locarnini, J. Fyfe, T. Sozzi, D. C. Jackson. 2002. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 293: 305-313.
- (2002) Virology , vol.293 , pp. 305-313
- Torresi, J.¹ Earnest-Silveira, L.² Deliyannis, G.³ Edgtton, K.⁴ Zhuang, H.⁵ Locarnini, S.A.⁶ Fyfe, J.⁷ Sozzi, T.⁸ Jackson, D.C.⁹

164
- 34047190745
- Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer?
- Trojan, J., M. Stuermer, G. Teuber, A. Berger, D. Faust. 2007. Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer? Gut 56: 436-437.
- (2007) Gut , vol.56 , pp. 436-437
- Trojan, J.¹ Stuermer, M.² Teuber, G.³ Berger, A.⁴ Faust, D.⁵

165
- 0024320276
- Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and PreS2 sequences
- Tron, F., F. Degos, C. Brechot, A. M. Courouce, A. Goudeau, F. N. Marie, P. Adamowicz, P. Saliou, A. Laplanche, J. P. Benhamou, M. Girard. 1989. Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and PreS2 sequences. J. Infect. Dis. 160:199-204.
- (1989) J. Infect. Dis. , vol.160 , pp. 199-204
- Tron, F.¹ Degos, F.² Brechot, C.³ Courouce, A.M.⁴ Goudeau, A.⁵ Marie, F.N.⁶ Adamowicz, P.⁷ Saliou, P.⁸ Laplanche, A.⁹ Benhamou, J.P.¹⁰ Girard, M.¹¹

166
- 0028855276
- Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation
- Truant, R., J. Antunovic, J. Greenblatt, C. Prives, J. A. Cromlish. 1995. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J. Virol. 69:1851-1859.
- (1995) J. Virol. , vol.69 , pp. 1851-1859
- Truant, R.¹ Antunovic, J.² Greenblatt, J.³ Prives, C.⁴ Cromlish, J.A.⁵

167
- 0037308267
- Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation
- Van Bommel, F., A. Schernick, U. Hopf, T. Berg. 2003. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation. Gastroenterology 124:586587.
- (2003) Gastroenterology , vol.124 , pp. 586-587
- Van Bommel, F.¹ Schernick, A.² Hopf, U.³ Berg, T.⁴

168
- 33747041958
- Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
- Van Bommel, F., B. Zollner, C. Sarrazin, U. Spengler, D. Huppe, B. Moller, H. H. Feucht, B. Wiedenmann, T. Berg. 2006. Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy. Hepatology 44:318-325.
- (2006) Hepatology , vol.44 , pp. 318-325
- Van Bommel, F.¹ Zollner, B.² Sarrazin, C.³ Spengler, U.⁴ Huppe, D.⁵ Moller, B.⁶ Feucht, H.H.⁷ Wiedenmann, B.⁸ Berg, T.⁹

169
- 1542724805
- Long-term follow-up of alphainterferon treatment of patients with chronic hepatitis B
- Van Zonneveld, M., P. Honkoop, B. E. Hansen, H. G. Niesters, S. D. Murad, R. A. de Man, S. W. Schalm, H. L. Janssen. 2004. Long-term follow-up of alphainterferon treatment of patients with chronic hepatitis B. Hepatology 39:804-810.
- (2004) Hepatology , vol.39 , pp. 804-810
- Van Zonneveld, M.¹ Honkoop, P.² Hansen, B.E.³ Niesters, H.G.⁴ Murad, S.D.⁵ De Man, R.A.⁶ Schalm, S.W.⁷ Janssen, H.L.⁸

170
- 0036895460
- Fanconi syndrome and renal failure induced by tenofovir: a first case report
- Verhelst, D., M. Monge, J. L. Meynard, B. Fouqueray, B. Mougenot, P. M. Girard, P. Ronco, J. Rossert. 2002. Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am. J. Kidney Dis. 40: 1331-1333.
- (2002) Am. J. Kidney Dis. , vol.40 , pp. 1331-1333
- Verhelst, D.¹ Monge, M.² Meynard, J.L.³ Fouqueray, B.⁴ Mougenot, B.⁵ Girard, P.M.⁶ Ronco, P.⁷ Rossert, J.⁸

171
- 17544369393
- Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
- Villeneuve, J. P., L. D. Condreay, B. Willems, G. Pomier-Layrargues, D. Fenyves, M. Bilodeau, R. Leduc, K. Peltekian, F. Wong, M. Margulies, E. J. Heathcote. 2000. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 31:207-210.
- (2000) Hepatology , vol.31 , pp. 207-210
- Villeneuve, J.P.¹ Condreay, L.D.² Willems, B.³ Pomier-Layrargues, G.⁴ Fenyves, D.⁵ Bilodeau, M.⁶ Leduc, R.⁷ Peltekian, K.⁸ Wong, F.⁹ Margulies, M.¹⁰ Heathcote, E.J.¹¹

172
- 33846492518
- Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein
- Visvanathan, K., N. A. Skinner, A. J. Thompson, S. M. Riordan, V. Sozzi, R. Edwards, S. Rodgers, J. Kurtovic, J. Chang, S. Lewin, P. Desmond, S. Lo-carnini. 2007. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45:102-110.
- (2007) Hepatology , vol.45 , pp. 102-110
- Visvanathan, K.¹ Skinner, N.A.² Thompson, A.J.³ Riordan, S.M.⁴ Sozzi, V.⁵ Edwards, R.⁶ Rodgers, S.⁷ Kurtovic, J.⁸ Chang, J.⁹ Lewin, S.¹⁰ Desmond, P.¹¹ Locarnini, S.¹²

173
- 34548475512
- Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients
- Volz, T., M. Lutgehetmann, P. Wachtler, A. Jacob, A. Quaas, J. M. Murray, M. Dandri, J. Petersen. 2007. Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 133:843-852.
- (2007) Gastroenterology , vol.133 , pp. 843-852
- Volz, T.¹ Lutgehetmann, M.² Wachtler, P.³ Jacob, A.⁴ Quaas, A.⁵ Murray, J.M.⁶ Dandri, M.⁷ Petersen, J.⁸

174
- 0028799577
- The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors
- Wachs, M. E., W. J. Amend, N. L. Ascher, P. N. Bre-tan, J. Emond, J. R. Lake, J. S. Melzer, J. P. Roberts, S. J. Tomlanovich, F. Vincenti, P. Stock. 1995. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 59:230-234.
- (1995) Transplantation , vol.59 , pp. 230-234
- Wachs, M.E.¹ Amend, W.J.² Ascher, N.L.³ Bretan, P.N.⁴ Emond, J.⁵ Lake, J.R.⁶ Melzer, J.S.⁷ Roberts, J.P.⁸ Tomlanovich, S.J.⁹ Vincenti, F.¹⁰ Stock, P.¹¹

175
- 0001655748
- Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, association with transcription factor ERCC3
- Wang, X. W., K. Forrester, H. Yeh, M. A. Feitelson, J. R. Gu, C. C. Harris. 1994. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, association with transcription factor ERCC3. Proc. Natl. Acad. Sci. USA 91: 2230-2234.
- (1994) Proc. Natl. Acad. Sci. USA , vol.91 , pp. 2230-2234
- Wang, X.W.¹ Forrester, K.² Yeh, H.³ Feitelson, M.A.⁴ Gu, J.R.⁵ Harris, C.C.⁶

176
- 0028834376
- Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
- Wang, X. W., M. K. Gibson, W. Vermeulen, H. Yeh, K. Forrester, H. W. Sturzbecher, J. H. Hoeijmakers, C. C. Harris. 1995. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 55:6012-6016.
- (1995) Cancer Res. , vol.55 , pp. 6012-6016
- Wang, X.W.¹ Gibson, M.K.² Vermeulen, W.³ Yeh, H.⁴ Forrester, K.⁵ Sturzbecher, H.W.⁶ Hoeijmakers, J.H.⁷ Harris, C.C.⁸

177
- 24344481036
- Molecular modeling of entecavir resistant mutations in the hepatitis B polymerase selected during therapy
- Warner, N., S. Locarnini, D. Colledge. 2004. Molecular modeling of entecavir resistant mutations in the hepatitis B polymerase selected during therapy. Hepatology 40:245A.
- (2004) Hepatology , vol.40 , pp. 245A
- Warner, N.¹ Locarnini, S.² Colledge, D.³

178
- 33947519044
- Surveillance for acute viral hepatitis-United States, 2005
- Wasley, A., J. T. Miller, L. Finelli. 2007. Surveillance for acute viral hepatitis-United States, 2005. Morb. Mortal. Wkly. Rep. Surveill. Summ. 56:1-24.
- (2007) Morb. Mortal. Wkly. Rep. Surveill. Summ. , vol.56 , pp. 1-24
- Wasley, A.¹ Miller, J.T.² Finelli, L.³

179
- 2442682870
- Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy
- Webster, G. J., S. Reignat, D. Brown, G. S. Ogg, L. Jones, S. L. Seneviratne, R. Williams, G. Dusheiko, A. Bertoletti. 2004. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J. Virol. 78:57075719.
- (2004) J. Virol. , vol.78 , pp. 5707-5719
- Webster, G.J.¹ Reignat, S.² Brown, D.³ Ogg, G.S.⁴ Jones, L.⁵ Seneviratne, S.L.⁶ Williams, R.⁷ Dusheiko, G.⁸ Bertoletti, A.⁹

180
- 0033754682
- Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms
- Webster, G. J., S. Reignat, M. K. Maini, S. A. Whalley, G. S. Ogg, A. King, D. Brown, P. L. Amlot, R. Williams, D. Vergani, G. M. Dusheiko, A. Bertoletti. 2000. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32: 1117-1124.
- (2000) Hepatology , vol.32 , pp. 1117-1124
- Webster, G.J.¹ Reignat, S.² Maini, M.K.³ Whalley, S.A.⁴ Ogg, G.S.⁵ King, A.⁶ Brown, D.⁷ Amlot, P.L.⁸ Williams, R.⁹ Vergani, D.¹⁰ Dusheiko, G.M.¹¹ Bertoletti, A.¹²

181
- 2942532722
- Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
- Werle-Lapostolle, B., S. Bowden, S. Locarnini, K. Wursthorn, J. Petersen, G. Lau, C. Trepo, P. Marcellin, Z. Goodman, W. E. Delaney IV, S. Xiong, C. L. Brosgart, S. S. Chen, C. S. Gibbs, F. Zoulim. 2004. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126:1750-1758.
- (2004) Gastroenterology , vol.126 , pp. 1750-1758
- Werle-Lapostolle, B.¹ Bowden, S.² Locarnini, S.³ Wursthorn, K.⁴ Petersen, J.⁵ Lau, G.⁶ Trepo, C.⁷ Marcellin, P.⁸ Goodman, Z.⁹ Delaney I.V, W.E.¹⁰ Xiong, S.¹¹ Brosgart, C.L.¹² Chen, S.S.¹³ Gibbs, C.S.¹⁴ Zoulim, F.¹⁵

182
- 0035794317
- Kinetics of acute hepatitis B virus infection in humans
- Whalley, S. A., J. M. Murray, D. Brown, G. J. Webster, V. C. Emery, G. M. Dusheiko, A. S. Perelson. 2001. Kinetics of acute hepatitis B virus infection in humans. J. Exp. Med. 193:847-854.
- (2001) J. Exp. Med. , vol.193 , pp. 847-854
- Whalley, S.A.¹ Murray, J.M.² Brown, D.³ Webster, G.J.⁴ Emery, V.C.⁵ Dusheiko, G.M.⁶ Perelson, A.S.⁷

183
- 2342588229
- Genomic analysis of the host response to hepatitis B virus infection
- Wieland, S., R. Thimme, R. H. Purcell, F. V. Chis-ari. 2004. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 101: 6669-6674.
- (2004) Proc. Natl. Acad. Sci. USA , vol.101 , pp. 6669-6674
- Wieland, S.¹ Thimme, R.² Purcell, R.H.³ Chisari, F.V.⁴

184
- 22544481160
- Stealth and cunning: hepatitis B and hepatitis C viruses
- Wieland, S. F., F. V. Chisari. 2005. Stealth and cunning: hepatitis B and hepatitis C viruses. J. Virol. 79: 9369-9380.
- (2005) J. Virol. , vol.79 , pp. 9369-9380
- Wieland, S.F.¹ Chisari, F.V.²

185
- 0023127729
- Replication strategy of human hepatitis B virus
- Will, H., W. Reiser, T. Weimer, E. Pfaff, M. Buscher, R. Sprengel, R. Cattaneo, H. Schaller. 1987. Replication strategy of human hepatitis B virus. J. Virol. 61: 904-911.
- (1987) J. Virol. , vol.61 , pp. 904-911
- Will, H.¹ Reiser, W.² Weimer, T.³ Pfaff, E.⁴ Buscher, M.⁵ Sprengel, R.⁶ Cattaneo, R.⁷ Schaller, H.⁸

186
- 0027378724
- Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B
- Wong, D. K., A. M. Cheung, K. O'Rourke, C. D. Naylor, A. S. Detsky, J. Heathcote. 1993. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann. Intern. Med. 119:312-323.
- (1993) A meta-analysis. Ann. Intern. Med. , vol.119 , pp. 312-323
- Wong, D.K.¹ Cheung, A.M.² O'Rourke, K.³ Naylor, C.D.⁴ Detsky, A.S.⁵ Heathcote, J.⁶

187
- 33748929265
- Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B
- Wursthorn, K., M. Lutgehetmann, M. Dandri, T. Volz, P. Buggisch, B. Zollner, T. Longerich, P. Schirmacher, F. Metzler, M. Zankel, C. Fischer, G. Currie, C. Bros-gart, J. Petersen. 2006. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 44:675-684.
- (2006) Hepatology , vol.44 , pp. 675-684
- Wursthorn, K.¹ Lutgehetmann, M.² Dandri, M.³ Volz, T.⁴ Buggisch, P.⁵ Zollner, B.⁶ Longerich, T.⁷ Schirmacher, P.⁸ Metzler, F.⁹ Zankel, M.¹⁰ Fischer, C.¹¹ Currie, G.¹² Brosgart, C.¹³ Petersen, J.¹⁴

188
- 0029922284
- A new pre-S containing recombinant hepatitis B vaccine and its effect on nonresponders: a preliminary observation
- Yap, I., S. H. Chan. 1996. A new pre-S containing recombinant hepatitis B vaccine and its effect on nonresponders: a preliminary observation. Ann. Acad. Med. Singap. 25:120-122.
- (1996) Ann. Acad. Med. Singap. , vol.25 , pp. 120-122
- Yap, I.¹ Chan, S.H.²

189
- 33748317138
- Evolution of multi-drug resistant hepatitis B virus during sequential therapy
- Yim, H. J., M. Hussain, Y. Liu, S. N. Wong, S. K. Fung, A. S. Lok. 2006. Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology 44:703-712.
- (2006) Hepatology , vol.44 , pp. 703-712
- Yim, H.J.¹ Hussain, M.² Liu, Y.³ Wong, S.N.⁴ Fung, S.K.⁵ Lok, A.S.⁶

190
- 33644506166
- Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005
- Yim, H. J., A. S. Lok. 2006. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43:S173-S181.
- (2006) Hepatology , vol.43 , pp. S173-S181
- Yim, H.J.¹ Lok, A.S.²

191
- 33846124558
- Hepatitis B virus is inhibited by RNA interference in cell culture and in mice
- Ying, R. S., C. Zhu, X. G. Fan, N. Li, X. F. Tian, H. B. Liu, B. X. Zhang. 2007. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice. Antivir. Res. 73:24-30.
- (2007) Antivir. Res. , vol.73 , pp. 24-30
- Ying, R.S.¹ Zhu, C.² Fan, X.G.³ Li, N.⁴ Tian, X.F.⁵ Liu, H.B.⁶ Zhang, B.X.⁷

192
- 13844322073
- Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men
- Yu, M. W., S. H. Yeh, P. J. Chen, Y. F. Liaw, C. L. Lin, C. J. Liu, W. L. Shih, J. H. Kao, D. S. Chen, C. J. Chen. 2005. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J. Natl. Cancer Inst. 97:265-272.
- (2005) J. Natl. Cancer Inst. , vol.97 , pp. 265-272
- Yu, M.W.¹ Yeh, S.H.² Chen, P.J.³ Liaw, Y.F.⁴ Lin, C.L.⁵ Liu, C.J.⁶ Shih, W.L.⁷ Kao, J.H.⁸ Chen, D.S.⁹ Chen, C.J.¹⁰

193
- 27444441182
- Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
- Yuen, M. F., H. J. Yuan, D. K. Wong, J. C. Yuen, W. M. Wong, A. O. Chan, B. C. Wong, K. C. Lai, C. L. Lai. 2005. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 54: 1610-1614.
- (2005) Gut , vol.54 , pp. 1610-1614
- Yuen, M.F.¹ Yuan, H.J.² Wong, D.K.³ Yuen, J.C.⁴ Wong, W.M.⁵ Chan, A.O.⁶ Wong, B.C.⁷ Lai, K.C.⁸ Lai, C.L.⁹

194
- 33847726708
- Changing patterns of acute viral hepatitis at a major urban referral center in Egypt
- Zakaria, S., R. Fouad, O. Shaker, S. Zaki, A. Hashem, S. S. El-Kamary, G. Esmat. 2007. Changing patterns of acute viral hepatitis at a major urban referral center in Egypt. Clin. Infect. Dis. 44:e30-e36.
- (2007) Clin. Infect. Dis. , vol.44 , pp. e30-e36
- Zakaria, S.¹ Fouad, R.² Shaker, O.³ Zaki, S.⁴ Hashem, A.⁵ El-Kamary, S.S.⁶ Esmat, G.⁷

195
- 0028013064
- Woodchuck hepatitis virus X protein is required for viral infection in vivo
- Zoulim, F., J. Saputelli, C. Seeger. 1994. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68:2026-2030.
- (1994) J. Virol. , vol.68 , pp. 2026-2030
- Zoulim, F.¹ Saputelli, J.² Seeger, C.³

196
- 0028091053
- Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase
- Zoulim, F., C. Seeger. 1994. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J. Virol. 68:6-13.
- (1994) J. Virol. , vol.68 , pp. 6-13
- Zoulim, F.¹ Seeger, C.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.